# 01æ€¥æ€§ç¼ºè¡€æ€§è„‘å’ä¸­æ‚£è€…ä¸€å¹´å†…ç»§å‘æ€§ç™«ç—«çš„é¢„æµ‹æ¨¡å‹
> ã€ŠPredictive models for secondary epilepsy in patients with acute ischemic stroke within one yearã€‹

## ä¸€ã€æ–‡çŒ®ä¿¡æ¯


| é¡¹ç›® | å†…å®¹ |
| ---- | ---- |
| æ ‡é¢˜ | æ€¥æ€§ç¼ºè¡€æ€§è„‘å’ä¸­æ‚£è€…ä¸€å¹´å†…ç»§å‘æ€§ç™«ç—«çš„é¢„æµ‹æ¨¡å‹ |
| ä½œè€… | Jinxin Liu, Haoyue He, Yanglingxi Wang ç­‰ |
| å‘è¡¨æ—¶é—´ | 2024å¹´11æœˆ14æ—¥ |
| å›½å®¶ | ä¸­å›½ |
| åˆ†åŒº | ä¸­ç§‘é™¢2åŒºï¼ˆeLifeæ‚å¿—ï¼‰ |
| å½±å“å› å­ | 7.7ï¼ˆ2023å¹´eLifeå½±å“å› å­ï¼‰ |
| æ‘˜è¦ | æœ¬ç ”ç©¶åŸºäºå››å®¶åŒ»é™¢21,459ä¾‹ç¼ºè¡€æ€§è„‘å’ä¸­æ‚£è€…æ•°æ®ï¼Œåˆ©ç”¨æœºå™¨å­¦ä¹ æ„å»ºå¹¶éªŒè¯äº†å¯è§£é‡Šæ€§å¼ºçš„æ¨¡å‹ä»¥é¢„æµ‹æ‚£è€…åœ¨ä¸€å¹´å†…å‘å±•ä¸ºç»§å‘æ€§ç™«ç—«çš„é£é™©ï¼Œæ ‘æ¨¡å‹ï¼ˆå¦‚RFã€XGBoostï¼‰é¢„æµ‹æ€§èƒ½ä¼˜è¶Šã€‚ |
| å…³é”®è¯ | ç¼ºè¡€æ€§è„‘å’ä¸­ï¼›ç»§å‘æ€§ç™«ç—«ï¼›æœºå™¨å­¦ä¹ ï¼›é¢„æµ‹æ¨¡å‹ï¼›SHAPè§£é‡Š |
| æœŸåˆŠåç§° | eLife |
| å·å·/æœŸå· | 2024å¹´ ç¬¬13å· |
| DOI | [10.7554/eLife.98759](https://doi.org/10.7554/eLife.98759) |
| ç ”ç©¶æ–¹æ³• | å›é¡¾æ€§å¤šä¸­å¿ƒé˜Ÿåˆ—ç ”ç©¶ï¼Œç»“åˆç»Ÿè®¡åˆ†æä¸9ç§æœºå™¨å­¦ä¹ ç®—æ³•ï¼Œä½¿ç”¨LASSOç­›é€‰å˜é‡ï¼ŒSHAPç”¨äºæ¨¡å‹è§£é‡Š |
| æ•°æ®æ¥æº | é‡åº†å››å®¶åŒ»é™¢2017â€“2022å¹´ä½é™¢è„‘å’ä¸­æ‚£è€…æ•°æ®åº“ï¼Œå¤–éƒ¨éªŒè¯æ¥è‡ª2022â€“2023å¹´ä¸‰å®¶åŒ»é™¢ |
| ç ”ç©¶ç»“æœ | NIHSSè¯„åˆ†ã€D-äºŒèšä½“ã€ç™½ç»†èƒè®¡æ•°ã€ä¹³é…¸ã€ASTã€CRPç­‰æ˜¯å…³é”®é¢„æµ‹å› ç´ ï¼ŒRFæ¨¡å‹åœ¨å¤–éƒ¨éªŒè¯ä¸­çµæ•åº¦è¾¾0.91ï¼ŒPPVä¸º0.95ï¼ŒAUCæ¥è¿‘0.99 |
| ç ”ç©¶ç»“è®º | æ„å»ºçš„æœºå™¨å­¦ä¹ æ¨¡å‹é¢„æµ‹å‡†ç¡®æ€§é«˜ï¼Œå…·ä¸´åºŠå®ç”¨æ€§ï¼Œå°¤å…¶åœ¨æ—©æœŸè¯†åˆ«é«˜é£é™©PSEæ‚£è€…æ–¹é¢å…·æœ‰é‡è¦ä»·å€¼ |
| ç ”ç©¶æ„ä¹‰ | ä¸ºæ€¥æ€§ç¼ºè¡€æ€§è„‘å’ä¸­åç™«ç—«çš„æ—©æœŸå¹²é¢„æä¾›æ•°æ®æ”¯æŒå’Œå†³ç­–ä¾æ®ï¼Œæœ‰æœ›æ”¹å–„æ‚£è€…é¢„å |


æœŸåˆŠåç§°ï¼šeLife
å½±å“å› å­ï¼š6.40
JCRåˆ†åŒºï¼šQ1
ä¸­ç§‘é™¢åˆ†åŒº(2025)ï¼šç”Ÿç‰©å­¦1åŒºÂ Top
å°ç±»ï¼šç”Ÿç‰©å­¦1åŒº
ä¸­ç§‘é™¢åˆ†åŒº(2023)ï¼šç”Ÿç‰©å­¦1åŒºÂ Top
å°ç±»ï¼šç”Ÿç‰©å­¦1åŒº
OPEN ACCESSï¼š99.60%
å‡ºç‰ˆå‘¨æœŸï¼šæš‚æ— æ•°æ®
æ˜¯å¦ç»¼è¿°ï¼šå¦
é¢„è­¦ç­‰çº§ï¼šæ— 
å¹´åº¦|å½±å“å› å­|å‘æ–‡é‡|è‡ªå¼•ç‡
2023 | 6.40 | 1332 | 1.6%
2022 | 7.70 | 1902 | 3.9%
2021 | 8.71 | 2003 | 3.7%
2020 | 8.15 | 1932 | 4.6%
2019 | 7.08 | 1513 | 4.6%



## äºŒã€æ ¸å¿ƒå†…å®¹
### ğŸ“Œ æ ¸å¿ƒå†…å®¹æ€»ç»“

æœ¬ç ”ç©¶é’ˆå¯¹æ€¥æ€§ç¼ºè¡€æ€§è„‘å’ä¸­ï¼ˆAISï¼‰æ‚£è€…åœ¨å‘ç—…ä¸€å¹´å†…å‘å±•ä¸ºç»§å‘æ€§ç™«ç—«ï¼ˆPSEï¼‰çš„é£é™©é¢„æµ‹é—®é¢˜ï¼Œæ”¶é›†äº†æ¥è‡ªé‡åº†åœ°åŒºå››å®¶åŒ»é™¢21,459åAISæ‚£è€…çš„ä¸´åºŠã€å½±åƒå’Œå®éªŒå®¤æ•°æ®ï¼Œæ„å»ºäº†ä¸€ä¸ª**å¯è§£é‡Šçš„æœºå™¨å­¦ä¹ é¢„æµ‹æ¨¡å‹**ã€‚æ¨¡å‹æ˜¾ç¤ºå‡ºæé«˜çš„é¢„æµ‹å‡†ç¡®æ€§ï¼Œå°¤å…¶æ˜¯æ ‘æ¨¡å‹ï¼ˆå¦‚éšæœºæ£®æ—ã€XGBoostã€LightGBMï¼‰è¡¨ç°ä¼˜å¼‚ï¼Œä¸ºä¸´åºŠæä¾›äº†æœ‰æ•ˆçš„PSEé£é™©è¯„ä¼°å·¥å…·ï¼Œæœ‰åŠ©äºæ—©æœŸè¯†åˆ«é«˜é£é™©æ‚£è€…ï¼Œå®ç°ç²¾å‡†å¹²é¢„ã€‚

### ğŸ“š ä¸»è¦å†…å®¹æ¢³ç†

#### ç ”ç©¶èƒŒæ™¯
- ç¼ºè¡€æ€§è„‘å’ä¸­æ˜¯è‡´æ­»ä¸è‡´æ®‹çš„ä¸»è¦åŸå› ï¼Œç»§å‘æ€§ç™«ç—«æ˜¯ä¸€ç§å¸¸è§å¹¶å‘ç—‡ï¼Œä¸¥é‡å½±å“ç”Ÿæ´»è´¨é‡ã€‚
- PSEå‘ç—…ç‡åœ¨3â€“30%ä¹‹é—´ï¼Œå…¶ä¸­**è¿‘ä¸€åŠå‘ç”Ÿåœ¨å’ä¸­åä¸€å¹´å†…**ã€‚
- ç›®å‰çš„é¢„æµ‹æ¨¡å‹å¤šä¸ºä¼ ç»Ÿç»Ÿè®¡æ–¹æ³•ï¼Œç¼ºä¹æ¨¡å‹æ€§èƒ½ä¸å¯è§£é‡Šæ€§ã€‚

#### æ•°æ®ä¸æ–¹æ³•
- **æ ·æœ¬é‡**ï¼š21,459åAISæ‚£è€…ï¼Œå¤–éƒ¨éªŒè¯é˜Ÿåˆ—ä¸º536äººã€‚
- **æ•°æ®æ¥æº**ï¼šé‡åº†å¸‚å››å®¶ä¸‰ç”²åŒ»é™¢ï¼Œ2017â€“2022å¹´ã€‚
- **æ–¹æ³•**ï¼š
  - ç¼ºå¤±å€¼å¡«è¡¥ï¼šéšæœºæ£®æ—æ³•ã€‚
  - ç‰¹å¾é€‰æ‹©ï¼šLASSOå›å½’ç­›é€‰å‡º20ä¸ªå…³é”®å˜é‡ã€‚
  - æ¨¡å‹æ„å»ºï¼šæ¯”è¾ƒ9ç§æœºå™¨å­¦ä¹ æ¨¡å‹ï¼ˆå«XGBoostã€RFã€LRç­‰ï¼‰ã€‚
  - ä¸å¹³è¡¡å¤„ç†ï¼šSMOTEENNæŠ€æœ¯ã€‚
  - æ¨¡å‹è§£é‡Šï¼šSHAPç®—æ³•è¯„ä¼°å˜é‡è´¡çŒ®ã€‚
  - éªŒè¯æ–¹å¼ï¼šå†…éƒ¨æµ‹è¯•é›†+å¤–éƒ¨éªŒè¯ã€‚

#### å…³é”®é¢„æµ‹å› å­
- ä¸´åºŠè¯„åˆ†ï¼š**NIHSSè¯„åˆ†**ï¼ˆå’ä¸­ä¸¥é‡ç¨‹åº¦ï¼‰
- è¡€æ¶²æŒ‡æ ‡ï¼š**ç™½ç»†èƒï¼ˆWBCï¼‰ã€D-äºŒèšä½“ã€ä¹³é…¸ã€ASTã€CRPã€CK-MBã€HbA1c**
- å…¶ä»–å› ç´ ï¼š**å¥³æ€§ã€å¹´é¾„å¤§ã€è„‘éƒ¨ç‰¹å®šåŒºåŸŸå—ç´¯ã€æ—¢å¾€é«˜è¡€å‹æˆ–æ·±é™è„‰è¡€æ “ç­‰å¹¶å‘ç—‡**

#### ä¸»è¦ç»“æœ
- **éšæœºæ£®æ—æ¨¡å‹è¡¨ç°æœ€ä½³**ï¼Œå†…éƒ¨æµ‹è¯•AUCè¾¾**0.99**ï¼Œå¤–éƒ¨éªŒè¯æ•æ„Ÿåº¦**0.91**ï¼Œé˜³æ€§é¢„æµ‹å€¼**0.95**ã€‚
- ä¸ä¼ ç»Ÿå›å½’æ¨¡å‹ç›¸æ¯”ï¼Œ**æ ‘æ¨¡å‹å…·æœ‰æ›´é«˜çš„æ€§èƒ½å’Œå¯è§£é‡Šæ€§**ã€‚
- SHAPè§£é‡Šå›¾æ¸…æ™°å±•ç¤ºäº†å„å˜é‡å¯¹é¢„æµ‹ç»“æœçš„å½±å“é¡ºåºå’Œæ–¹å‘ã€‚

#### ç ”ç©¶ç»“è®º
- æœ¬ç ”ç©¶æä¾›äº†ä¸€ä¸ªé«˜æ•ˆã€é€æ˜ã€å¯æ‰©å±•çš„PSEé¢„æµ‹å·¥å…·ã€‚
- æœ‰åŠ©äºä¸´åºŠåŒ»ç”Ÿåœ¨AISæ‚£è€…æ—©æœŸè¯†åˆ«ç™«ç—«é«˜é£é™©äººç¾¤ï¼Œåˆ¶å®šä¸ªä½“åŒ–ç®¡ç†æ–¹æ¡ˆã€‚

#### ç ”ç©¶å±€é™
- åœ°åŸŸæ€§æ•°æ®ï¼ˆä¸»è¦æ¥è‡ªé‡åº†ï¼‰ï¼Œä»£è¡¨æ€§æœ‰é™ã€‚
- å›é¡¾æ€§è®¾è®¡ï¼Œéƒ¨åˆ†æ½œåœ¨é¢„æµ‹å› å­ï¼ˆå¦‚æ¿€ç´ æ°´å¹³ï¼‰æœªèƒ½çº³å…¥ã€‚
- æœªæ¥å»ºè®®å¼€å±•å¤šä¸­å¿ƒã€å‰ç»æ€§ç ”ç©¶ï¼Œå¹¶å¼•å…¥æ›´å…¨é¢çš„æ•°æ®ç‰¹å¾ã€‚



## ä¸‰ã€ğŸ“– æ–‡çŒ®ç»“æ„ä¸å†…å®¹æ€»ç»“

---

### Introductionï¼ˆå¼•è¨€ï¼‰

- **èƒŒæ™¯é—®é¢˜**ï¼šç»§å‘æ€§ç™«ç—«ï¼ˆPSEï¼‰æ˜¯æ€¥æ€§ç¼ºè¡€æ€§è„‘å’ä¸­ï¼ˆAISï¼‰æ‚£è€…å¸¸è§å¹¶å‘ç—‡ï¼Œå½±å“é¢„åä¸ç”Ÿæ´»è´¨é‡ï¼Œçº¦åŠæ•°PSEå‘ç”Ÿåœ¨å’ä¸­ä¸€å¹´å†…ã€‚
- **ç ”ç©¶ç°çŠ¶**ï¼šä¼ ç»Ÿé¢„æµ‹æ–¹æ³•ï¼ˆå¦‚Coxã€çº¿æ€§å›å½’ï¼‰å±€é™æ€§å¤§ï¼Œæ–°è¿‘è™½æœ‰åŸºäºå½±åƒç»„å­¦çš„æ¨¡å‹ï¼Œä½†å¯è§£é‡Šæ€§å’Œæ¨å¹¿æ€§ä¸è¶³ã€‚
- **ç ”ç©¶ç›®çš„**ï¼šæœ¬ç ”ç©¶æ—¨åœ¨åˆ©ç”¨å¤šä¸­å¿ƒå¤§è§„æ¨¡çœŸå®ä¸–ç•Œæ•°æ®ï¼Œç»“åˆå¯è§£é‡Šæ€§æœºå™¨å­¦ä¹ æ¨¡å‹ï¼Œæå‡PSEé£é™©é¢„æµ‹å‡†ç¡®åº¦å’Œä¸´åºŠå®ç”¨æ€§ã€‚

---

### Resultsï¼ˆç»“æœï¼‰

#### â–¶ï¸ æ•°æ®å¡«è¡¥ä¸æ ·æœ¬ä¿¡æ¯

- ä½¿ç”¨**éšæœºæ£®æ—ç®—æ³•**å¡«è¡¥å®éªŒå®¤æ•°æ®ç¼ºå¤±é¡¹ã€‚
- çº³å…¥**21,459ä¾‹AISæ‚£è€…**ï¼ŒPSEå‘ç”Ÿç‡ä¸º4.3%ï¼›å¤–éƒ¨éªŒè¯é›†536ä¾‹ã€‚

#### â–¶ï¸ é£é™©å› ç´ åˆ†æ

- PSEé«˜é£é™©æ‚£è€…å¸¸ä¼´æœ‰ï¼š**è„‘ç–ã€æ°´è„‘ã€DVTã€æˆ¿é¢¤ã€å°¿æ¯’ç—‡ã€çš®è´¨/ä¸˜è„‘/é¢é¡¶å¶å—ç´¯**ã€‚
- å®éªŒå®¤æŒ‡æ ‡ä¸­ï¼š**WBCã€D-äºŒèšä½“ã€ä¹³é…¸ã€ASTã€CRPã€HbA1c**ä¸PSEæ˜¾è‘—ç›¸å…³ã€‚

#### â–¶ï¸ æ¨¡å‹æ€§èƒ½æ¯”è¾ƒ

- **æ ‘æ¨¡å‹ï¼ˆRFã€XGBoostã€LightGBMï¼‰è¡¨ç°æœ€ä¼˜**ï¼ŒAUCé«˜è¾¾**0.99**ã€‚
- å¤–éƒ¨éªŒè¯ä¸­ï¼ŒRFæ¨¡å‹æ•æ„Ÿåº¦è¾¾**0.91**ï¼Œé˜³æ€§é¢„æµ‹å€¼**0.95**ï¼Œæ ¡å‡†æ›²çº¿ä¸å†³ç­–æ›²çº¿è¡¨ç°è‰¯å¥½ã€‚

#### â–¶ï¸ SHAPåˆ†æ

- æœ€é‡è¦çš„é¢„æµ‹å› å­ï¼š**WBC > NIHSS > D-äºŒèšä½“ > AST**ã€‚
- å¥³æ€§ã€é«˜NIHSSè¯„åˆ†ä¸é«˜é£é™©æ­£ç›¸å…³ï¼›ä½APTTã€Pltä¹Ÿæé«˜é£é™©ã€‚
- SHAPåŠ›å›¾ä¸å†³ç­–å›¾å±•ç¤ºæ¨¡å‹å¯¹ä¸ªä½“é¢„æµ‹çš„å¯è§£é‡Šæ€§ã€‚

---

### Discussionï¼ˆè®¨è®ºï¼‰

- æœ¬ç ”ç©¶æ¨¡å‹**æ€§èƒ½ä¼˜äºä¼ ç»Ÿç»Ÿè®¡æ–¹æ³•**ï¼Œä¸”å…·è¾ƒé«˜å¯è§£é‡Šæ€§ã€‚
- ä¸æ—¢å¾€æ–‡çŒ®æ¯”è¾ƒï¼šéƒ¨åˆ†å˜é‡ï¼ˆå¦‚æ€§åˆ«ã€å¹´é¾„ï¼‰åœ¨ä¸åŒç ”ç©¶é—´å­˜åœ¨ä¸ä¸€è‡´ã€‚
- **æ¨¡å‹ä¼˜åŠ¿**ï¼š
  - å¯å¤„ç†éçº¿æ€§å…³ç³»ï¼›
  - é€‚ç”¨äºå¤§è§„æ¨¡æ•°æ®ï¼›
  - SHAPå¯æ­ç¤ºç‰¹å¾å½±å“æ–¹å‘ä¸é‡è¦æ€§ã€‚
- **å±€é™æ€§**ï¼š
  - æ•°æ®æ¥è‡ªé‡åº†åœ°åŒºï¼Œ**åœ°ç†å±€é™æ€§**ï¼›
  - å›é¡¾æ€§ç ”ç©¶ï¼Œå­˜åœ¨**æ½œåœ¨åå€š**ï¼›
  - ç¼ºå¤±éƒ¨åˆ†æ½œåœ¨é‡è¦å˜é‡ï¼ˆå¦‚æ¿€ç´ ã€è¡€æµå˜å­¦æŒ‡æ ‡ç­‰ï¼‰ã€‚

---

### Materials and Methodsï¼ˆææ–™ä¸æ–¹æ³•ï¼‰

#### âœ… ç ”ç©¶è®¾è®¡

- **ç±»å‹**ï¼šå¤šä¸­å¿ƒå›é¡¾æ€§é˜Ÿåˆ—ç ”ç©¶ã€‚
- **çº³æ’æ ‡å‡†**ï¼š18â€“90å²æ–°å‘AISæ‚£è€…ï¼Œæ’é™¤æ—¢å¾€ç™«ç—«ã€çŸ­æš‚æ€§è„‘ç¼ºè¡€å‘ä½œï¼ˆTIAï¼‰ã€è„‘è‚¿ç˜¤ã€è„‘å¤–ä¼¤ç­‰ã€‚

#### âœ… æ•°æ®å¤„ç†

- **ç¼ºå¤±å€¼å¤„ç†**ï¼šéšæœºæ£®æ—é€å˜é‡å¡«è¡¥ã€‚
- **ç±»åˆ«å˜é‡**ï¼šone-hotç¼–ç ã€‚
- **ç‰¹å¾ç­›é€‰**ï¼šLASSOæ–¹æ³•é€‰å‡º20ä¸ªå…³é”®å˜é‡ã€‚

#### âœ… æ¨¡å‹æ„å»ºä¸è¯„ä¼°

- å…±æ„å»º9ç§æœºå™¨å­¦ä¹ æ¨¡å‹ï¼ˆå«RFã€XGBoostã€KNNç­‰ï¼‰ï¼Œé‡‡ç”¨ç½‘æ ¼æœç´¢ä¼˜åŒ–å‚æ•°ã€‚
- **ä¸å¹³è¡¡æ•°æ®å¤„ç†**ï¼šä½¿ç”¨SMOTEENNæŠ€æœ¯æå‡æ¨¡å‹ç¨³å®šæ€§ã€‚
- æ¨¡å‹è¯„ä»·æŒ‡æ ‡ï¼šAUCã€F1ã€å‡†ç¡®ç‡ã€æ•æ„Ÿåº¦ã€ç‰¹å¼‚æ€§ç­‰ã€‚
- æœ€ç»ˆä½¿ç”¨**SHAPç®—æ³•**è¿›è¡Œæ¨¡å‹è§£é‡Šå’Œç‰¹å¾å½±å“å¯è§†åŒ–ã€‚

---

### Conclusionï¼ˆç»“è®ºï¼‰

- æˆåŠŸæ„å»ºäº†**é«˜æ€§èƒ½ã€å¯è§£é‡Šçš„æœºå™¨å­¦ä¹ æ¨¡å‹**ç”¨äºé¢„æµ‹AISæ‚£è€…ä¸€å¹´å†…PSEå‘ç”Ÿé£é™©ã€‚
- **NIHSSã€WBCã€D-äºŒèšä½“ã€ä¹³é…¸ã€ASTç­‰ä¸ºå…³é”®é¢„æµ‹å› å­**ã€‚
- ä¸ºä¸´åºŠæä¾›æ—©æœŸé£é™©è¯†åˆ«ä¸ä¸ªä½“åŒ–å¹²é¢„çš„ä¾æ®ã€‚
- å»ºè®®æœªæ¥å¼€å±•**å‰ç»æ€§ã€å¤šä¸­å¿ƒç ”ç©¶**è¿›ä¸€æ­¥éªŒè¯å’Œä¼˜åŒ–æ¨¡å‹ã€‚

---


## å››ã€ğŸ“‹ æ–¹æ³•ä¸å®æ–½è®¡åˆ’è¯¦è§£

---

### ç ”ç©¶è®¾è®¡ä¸å¯¹è±¡

- **ç ”ç©¶ç±»å‹**ï¼šå¤šä¸­å¿ƒã€å›é¡¾æ€§é˜Ÿåˆ—ç ”ç©¶ã€‚
- **ç ”ç©¶ç›®çš„**ï¼šæ„å»ºä¸€ä¸ªåŸºäºå¤šæ¨¡æ€æ•°æ®ï¼ˆä¸´åºŠ+å½±åƒ+å®éªŒå®¤ï¼‰çš„å¯è§£é‡Šæ€§æœºå™¨å­¦ä¹ æ¨¡å‹ï¼Œç”¨äºé¢„æµ‹AISæ‚£è€…åœ¨ä¸€å¹´å†…å‘ç”Ÿç»§å‘æ€§ç™«ç—«ï¼ˆPSEï¼‰çš„é£é™©ã€‚
- **çº³å…¥æ—¶é—´**ï¼š
  - **è®­ç»ƒä¸æµ‹è¯•æ•°æ®**ï¼š2017å¹´6æœˆ â€“ 2022å¹´6æœˆï¼ˆé‡åº†æ€¥æ•‘åŒ»ç–—ä¸­å¿ƒç­‰4å®¶åŒ»é™¢ï¼‰
  - **å¤–éƒ¨éªŒè¯æ•°æ®**ï¼š2022å¹´7æœˆ â€“ 2023å¹´7æœˆï¼ˆä¸‰å®¶å¤–éƒ¨åŒ»é™¢ï¼‰
- **æ ·æœ¬é‡**ï¼š
  - åŸå§‹æ•°æ®42,079ä¾‹
  - æœ€ç»ˆå…¥ç»„21,459ä¾‹AISæ–°å‘æ‚£è€…ï¼ˆå»é™¤æ—¢å¾€å’ä¸­ã€TIAã€è„‘è‚¿ç˜¤ã€ç™«ç—«å²ç­‰ï¼‰

#### â–¶ï¸ çº³å…¥æ ‡å‡†
1. å¹´é¾„åœ¨18â€“90å²ä¹‹é—´
2. é¦–æ¬¡è¯Šæ–­ä¸º**æ€¥æ€§ç¼ºè¡€æ€§è„‘å’ä¸­ï¼ˆAISï¼‰**
3. å®Œæ•´çš„ä¸´åºŠã€å½±åƒå’Œå®éªŒå®¤æ•°æ®

#### â–¶ï¸ æ’é™¤æ ‡å‡†
- æ—¢å¾€å’ä¸­ã€TIAç—…å²
- ç™«ç—«æˆ–æŠ—ç™«ç—«è¯ä½¿ç”¨å²
- è„‘å¤–ä¼¤ã€è„‘è‚¿ç˜¤ã€è„‘è¡€ç®¡ç•¸å½¢ç­‰ä¼šå¼•å‘ç™«ç—«çš„ç–¾ç—…
- å‘ç—…72å°æ—¶å†…æ­»äº¡
- éšè®¿ä¸¢å¤±æˆ–3ä¸ªæœˆå†…æ­»äº¡

---

### æ•°æ®é‡‡é›†ä¸å˜é‡ç±»å‹

å…±é‡‡é›†äº”ç±»æ•°æ®ï¼Œæ•´åˆä¸ºå¤šæ¨¡æ€è¾“å…¥ç‰¹å¾ï¼š

1. **ä¸€èˆ¬ä¿¡æ¯**ï¼šæ€§åˆ«ã€å¹´é¾„ã€NIHSSè¯„åˆ†
2. **åˆå¹¶ç—‡ä¸å¹¶å‘ç—‡**ï¼šå¦‚é«˜è¡€å‹ã€ç³–å°¿ç—…ã€DVTã€è„‘ç–ã€æ°´è„‘ã€ä½è›‹ç™½è¡€ç—‡ç­‰
3. **è„‘éƒ¨å—ç´¯åŒºåŸŸï¼ˆå½±åƒæ•°æ®ï¼‰**ï¼šé¢å¶ã€é¡¶å¶ã€é¢å¶ã€ä¸˜è„‘ã€åŸºåº•èŠ‚ã€è„‘å¹²ã€çš®å±‚/çš®è´¨ä¸‹ç­‰
4. **è¡€ç®¡å½±åƒå­¦æ•°æ®**ï¼šåŒ…æ‹¬ACA/MCA/PCA/VA/BAç­‰ä¸»è¦è„‘åŠ¨è„‰çš„ç‹­çª„æˆ–é—­å¡æƒ…å†µ
5. **å…³é”®å®éªŒå®¤æŒ‡æ ‡**ï¼š
   - è¡€è„‚ï¼šTGã€HDLã€LDL
   - è‚åŠŸèƒ½ï¼šALTã€ASTã€æ€»èƒ†çº¢ç´ ã€ç™½è›‹ç™½
   - è‚¾åŠŸèƒ½ï¼šå°¿ç´ ã€è‚Œé…ã€å°¿é…¸
   - è¡€æ°”ï¼šä¹³é…¸ã€é˜´ç¦»å­é—´éš™ã€TCOâ‚‚
   - å‡è¡€ï¼šINRã€PTã€APTTã€TTã€D-äºŒèšä½“ã€çº¤ç»´è›‹ç™½åŸ
   - å¿ƒè‚Œé…¶è°±ï¼šCKã€CK-MBã€LDHã€IMAã€HBDH

---

### æ•°æ®å¤„ç†æµç¨‹

#### 1ï¸âƒ£ ç¼ºå¤±å€¼å¤„ç†
- **ç­–ç•¥**ï¼šéšæœºæ£®æ—æ’è¡¥æ³•ï¼ˆRFï¼‰ï¼Œä¸€åˆ—ä¸€åˆ—è¿­ä»£å¡«è¡¥ï¼Œå…ˆå¡«ç¼ºå¤±å°‘çš„å˜é‡ã€‚

#### 2ï¸âƒ£ ç‰¹å¾å·¥ç¨‹
- ç±»åˆ«å˜é‡é‡‡ç”¨ **One-Hotç¼–ç **
- ä½¿ç”¨ **LASSOå›å½’** è¿›è¡Œç‰¹å¾ç­›é€‰ï¼Œæå–20ä¸ªæœ€é‡è¦å˜é‡ç”¨äºå»ºæ¨¡

#### 3ï¸âƒ£ æ•°æ®åˆ’åˆ†
- å°†å…¨éƒ¨æ•°æ®é›†æŒ‰**7:3**æ¯”ä¾‹åˆ’åˆ†ä¸ºè®­ç»ƒé›†ï¼ˆ15,021ä¾‹ï¼‰å’Œæµ‹è¯•é›†ï¼ˆ6,438ä¾‹ï¼‰

#### 4ï¸âƒ£ æ•°æ®ä¸å¹³è¡¡å¤„ç†
- å› PSEå‘ç”Ÿç‡ä»…ä¸º4.3%ï¼Œå­˜åœ¨æ ·æœ¬æåº¦ä¸å¹³è¡¡
- é‡‡ç”¨ **SMOTEENNï¼ˆåˆæˆå°‘æ•°ç±»è¿‡é‡‡æ ·+ç¼–è¾‘æœ€è¿‘é‚»ï¼‰** æ–¹æ³•å¢å¼ºæ­£æ ·æœ¬ï¼Œå¹³è¡¡è®­ç»ƒæ•°æ®

---

### æ¨¡å‹æ„å»ºä¸è¯„ä¼°

#### â–¶ï¸ æ¨¡å‹ç±»å‹ï¼ˆå…±9ç§ï¼‰
- Logistic Regressionï¼ˆLRï¼‰
- Naive Bayes
- Decision Tree
- Random Forestï¼ˆRFï¼‰
- Gradient Boosting
- XGBoost
- LightGBM
- Multi-layer Perceptronï¼ˆMLPï¼‰
- K-Nearest Neighborsï¼ˆKNNï¼‰

#### â–¶ï¸ å‚æ•°ä¼˜åŒ–
- **ç½‘æ ¼æœç´¢**è°ƒå‚ï¼ˆGrid Searchï¼‰
- æŒ‡æ ‡åŒ…æ‹¬å‡†ç¡®ç‡ã€çµæ•åº¦ã€ç‰¹å¼‚åº¦ã€F1ã€PPVã€NPVã€AUC

#### â–¶ï¸ æ¨¡å‹è¯„ä¼°æ–¹å¼
- å†…éƒ¨æµ‹è¯•é›†è¯„ä¼°
- å¤–éƒ¨éªŒè¯é›†ï¼ˆ536ä¾‹ï¼‰æµ‹è¯•æ³›åŒ–èƒ½åŠ›
- **ROCæ›²çº¿ã€æ ¡å‡†æ›²çº¿ï¼ˆCalibrationï¼‰ã€å†³ç­–æ›²çº¿ï¼ˆDCAï¼‰**è¿›è¡Œç»¼åˆè¯„ä¼°

---

### æ¨¡å‹è§£é‡Šæ€§åˆ†æ

- ä½¿ç”¨ **SHAPï¼ˆSHapley Additive exPlanationsï¼‰** æ–¹æ³•è¯„ä¼°å˜é‡å¯¹æ¨¡å‹è¾“å‡ºçš„å…·ä½“è´¡çŒ®
- äº§å‡ºï¼š
  - **SHAP Summary Plot**ï¼šå±•ç¤ºå˜é‡é‡è¦æ€§
  - **Force Plot**ï¼šå±•ç¤ºå•ä¸ªé¢„æµ‹æ ·æœ¬ä¸­æ¯ä¸ªå˜é‡å¯¹ç»“æœçš„å½±å“æ–¹å‘ä¸å¤§å°
  - **Decision Plot**ï¼šå±•ç¤ºå¤šæ ·æœ¬ä¸­å˜é‡å¦‚ä½•æ¨åŠ¨æ¨¡å‹ä½œå‡ºä¸åŒé¢„æµ‹

---

### ç»Ÿè®¡æ–¹æ³•

- **ç»Ÿè®¡åˆ†æå·¥å…·**ï¼šPythonä¸­çš„`scipy.stats`
- æ­£æ€æ€§æ£€éªŒï¼šShapiro-Wilk
- æ–¹å·®é½æ€§æ£€éªŒï¼šLeveneæ£€éªŒ
- ç»„é—´æ¯”è¾ƒï¼š
  - æ­£æ€åˆ†å¸ƒ â†’ tæ£€éªŒæˆ–Welchæ£€éªŒ
  - éæ­£æ€åˆ†å¸ƒ â†’ Mann-Whitney Uæ£€éªŒ
  - åˆ†ç±»å˜é‡ â†’ å¡æ–¹æ£€éªŒ
- è¯„ä¼°æŒ‡æ ‡ï¼š
  - **ç½®ä¿¡åŒºé—´**ï¼šAUCä¸Brier Scoreé€šè¿‡1000æ¬¡Bootstrapè®¡ç®—
  - **åˆ†ç±»é˜ˆå€¼**ï¼šåŸºäºè®­ç»ƒé›†æœ€å¤§Youden Indexè®¾å®š

---



## äº”ã€é‡è¦å˜é‡å’Œæ•°æ®(è‹±æ–‡å±•ç¤º)

---

### ğŸ“Š Continuous Variables Summary

| Variable     | Mean | Std  | Median | Min  | Max  |
|--------------|------|------|--------|------|------|
| NIHSS        | 7.2  | 3.1  | 7      | 0    | 24   |
| WBC          | 8.5  | 2.3  | 8.4    | 3.2  | 18.1 |
| D-dimer      | 0.98 | 0.45 | 0.92   | 0.1  | 2.6  |
| Lactate      | 1.8  | 0.6  | 1.75   | 0.5  | 4.0  |
| AST          | 25.4 | 10.7 | 24     | 10   | 75   |
| CRP          | 9.1  | 4.2  | 8.8    | 1.2  | 23.5 |
| HbA1c        | 6.4  | 1.1  | 6.2    | 4.8  | 10.2 |
| CK-MB        | 18.5 | 5.6  | 17.9   | 5.2  | 45.0 |

---

### ğŸ“‹ Categorical Variables Summary

| Variable             | Positive_Count | Negative_Count | Positive_Ratio | Negative_Ratio |
|----------------------|----------------|----------------|----------------|----------------|
| Sex (Female)         | 522            | 8512           | 0.547          | 0.409          |
| Hypertension         | 645            | 12003          | 0.676          | 0.577          |
| DVT                  | 87             | 645            | 0.091          | 0.031          |
| Atrial fibrillation  | 164            | 2017           | 0.172          | 0.097          |
| Hyperuricemia        | 128            | 1583           | 0.134          | 0.076          |
| Hydrocephalus        | 104            | 512            | 0.109          | 0.025          |
| Fatty liver          | 89             | 4021           | 0.093          | 0.193          |

---



## äº”ã€é‡è¦å˜é‡å’Œæ•°æ®(ä¸­æ–‡å±•ç¤º)

---

### ğŸ“Š è¿ç»­å˜é‡æ±‡æ€»è¡¨

| å˜é‡åç§°     | å¹³å‡å€¼ | æ ‡å‡†å·® | ä¸­ä½æ•° | æœ€å°å€¼ | æœ€å¤§å€¼ |
|--------------|--------|--------|--------|--------|--------|
| NIHSSè¯„åˆ†     | 7.2    | 3.1    | 7      | 0      | 24     |
| ç™½ç»†èƒï¼ˆWBCï¼‰ | 8.5    | 2.3    | 8.4    | 3.2    | 18.1   |
| D-äºŒèšä½“      | 0.98   | 0.45   | 0.92   | 0.1    | 2.6    |
| ä¹³é…¸ï¼ˆLactateï¼‰ | 1.8    | 0.6    | 1.75   | 0.5    | 4.0    |
| å¤©é—¨å†¬æ°¨é…¸è½¬æ°¨é…¶ï¼ˆASTï¼‰ | 25.4   | 10.7   | 24     | 10     | 75     |
| Cååº”è›‹ç™½ï¼ˆCRPï¼‰ | 9.1    | 4.2    | 8.8    | 1.2    | 23.5   |
| ç³–åŒ–è¡€çº¢è›‹ç™½ï¼ˆHbA1cï¼‰ | 6.4    | 1.1    | 6.2    | 4.8    | 10.2   |
| è‚Œé…¸æ¿€é…¶åŒå·¥é…¶ï¼ˆCK-MBï¼‰ | 18.5   | 5.6    | 17.9   | 5.2    | 45.0   |

---

### ğŸ“‹ åˆ†ç±»å˜é‡æ±‡æ€»è¡¨

| å˜é‡åç§°         | PSEé˜³æ€§äººæ•° | PSEé˜´æ€§äººæ•° | é˜³æ€§æ„æˆæ¯” | é˜´æ€§æ„æˆæ¯” |
|------------------|--------------|--------------|------------|------------|
| å¥³æ€§              | 522          | 8512         | 0.547      | 0.409      |
| é«˜è¡€å‹            | 645          | 12003        | 0.676      | 0.577      |
| æ·±é™è„‰è¡€æ “ï¼ˆDVTï¼‰ | 87           | 645          | 0.091      | 0.031      |
| æˆ¿é¢¤              | 164          | 2017         | 0.172      | 0.097      |
| é«˜å°¿é…¸è¡€ç—‡        | 128          | 1583         | 0.134      | 0.076      |
| è„‘ç§¯æ°´            | 104          | 512          | 0.109      | 0.025      |
| è„‚è‚ªè‚            | 89           | 4021         | 0.093      | 0.193      |

---


## å…­ã€æ¨¡æ‹Ÿæ•°æ®
è¯·ä½ æ ¹æ®ä¸Šè¿°æŠ“å–çš„æ•°æ®ä¿¡æ¯ï¼Œç»™å‡ºpythonä»£ç ï¼Œå¹¶ç»™è¿™ä»½ä»£ç å–ä¸ªåå­—ï¼Œç”¨äºæ¨¡æ‹Ÿä¸Šè¿°æ•°æ®ï¼Œæœ€ç»ˆä¿å­˜ä¸ºcsvæ ¼å¼ï¼Œä¿å­˜çš„è·¯å¾„ä¸º04æ–‡çŒ®é˜…è¯»\08ç¥ç»å†…ç§‘\01æ€¥æ€§ç¼ºè¡€æ€§è„‘å’ä¸­æ‚£è€…ä¸€å¹´å†…ç»§å‘æ€§ç™«ç—«çš„é¢„æµ‹æ¨¡å‹\03æ¨¡æ‹Ÿæ•°æ®\01data


## ä¸ƒã€å¤ç°ä»£ç 
è¯·ä½ æ ¹æ®ä¸Šè¿°ç”Ÿæˆçš„æ•°æ®ï¼ŒæŒ‰ç…§è¿™ç¯‡æ–‡çŒ®çš„æ€è·¯å’Œæ–¹æ³•ï¼Œç»™å‡ºpythonä»£ç ï¼Œå¹¶ç»™è¿™ä»½ä»£ç å–ä¸ªåå­—ï¼Œç”¨äºå¤ç°ä¸Šè¿°æ–‡çŒ®ä¸­çš„ç»“æœï¼Œä¸‹è¿°å†…å®¹æ˜¯ä½ åˆšåˆšç»™æˆ‘çš„å®æ–½è®¡åˆ’ï¼Œä¾›ä½ å‚è€ƒï¼š







# åŸæ–‡(æä¾›åŸå§‹ä»£ç )
01æ€¥æ€§ç¼ºè¡€æ€§è„‘å’ä¸­æ‚£è€…ä¸€å¹´å†…ç»§å‘æ€§ç™«ç—«çš„é¢„æµ‹æ¨¡å‹
Predictive models for secondary epilepsy in patients with acute ischemic stroke within one year

## Abstract  æ‘˜è¦
### Background:  èƒŒæ™¯èµ„æ–™ï¼š
Post-stroke epilepsy (PSE) is a critical complication that worsens both prognosis and quality of life in patients with ischemic stroke. An interpretable machine learning model was developed to predict PSE using medical records from four hospitals in Chongqing.
å’ä¸­åç™«ç—«ï¼ˆPSEï¼‰æ˜¯å½±å“ç¼ºè¡€æ€§å’ä¸­æ‚£è€…é¢„åå’Œç”Ÿæ´»è´¨é‡çš„é‡è¦å¹¶å‘ç—‡ã€‚åˆ©ç”¨é‡åº†å¸‚ 4 å®¶åŒ»é™¢çš„ç—…å†èµ„æ–™ï¼Œå»ºç«‹äº†ä¸€ä¸ªå¯è§£é‡Šçš„æœºå™¨å­¦ä¹ æ¨¡å‹æ¥é¢„æµ‹ PSEã€‚

### Methods:  ç ”ç©¶æ–¹æ³•ï¼š
Medical records, imaging reports, and laboratory test results from 21,459 ischemic stroke patients were collected and analyzed. Univariable and multivariable statistical analyses identified key predictive factors. The dataset was split into a 70% training set and a 30% testing set. To address the class imbalance, the Synthetic Minority Oversampling Technique combined with Edited Nearest Neighbors was employed. Nine widely used machine learning algorithms were evaluated using relevant prediction metrics, with SHAP (SHapley Additive exPlanations) used to interpret the model and assess the contributions of different features.
æ”¶é›†å¹¶åˆ†æäº† 21,459 ä¾‹ç¼ºè¡€æ€§å’ä¸­æ‚£è€…çš„ç—…å†ã€å½±åƒå­¦æŠ¥å‘Šå’Œå®éªŒå®¤æ£€æŸ¥ç»“æœã€‚å•å˜é‡å’Œå¤šå˜é‡ç»Ÿè®¡åˆ†æç¡®å®šäº†å…³é”®çš„é¢„æµ‹å› ç´ ã€‚è¯¥æ•°æ®é›†åˆ†ä¸º 70%çš„è®­ç»ƒé›†å’Œ 30%çš„æµ‹è¯•é›†ã€‚ä¸ºäº†è§£å†³ç±»åˆ«ä¸å¹³è¡¡ï¼Œé‡‡ç”¨äº†åˆæˆå°‘æ•°è¿‡é‡‡æ ·æŠ€æœ¯ç»“åˆç¼–è¾‘æœ€è¿‘é‚»ã€‚ä½¿ç”¨ç›¸å…³çš„é¢„æµ‹æŒ‡æ ‡è¯„ä¼°äº†ä¹ç§å¹¿æ³›ä½¿ç”¨çš„æœºå™¨å­¦ä¹ ç®—æ³•ï¼ŒSHAPï¼ˆSHapley Additive exPlanationsï¼‰ç”¨äºè§£é‡Šæ¨¡å‹å¹¶è¯„ä¼°ä¸åŒç‰¹å¾çš„è´¡çŒ®ã€‚

### Results:  ç»“æœå¦‚ä¸‹ï¼š
Regression analyses revealed that complications such as hydrocephalus, cerebral hernia, and deep vein thrombosis, as well as specific brain regions (frontal, parietal, and temporal lobes), significantly contributed to PSE. Factors such as age, gender, NIH Stroke Scale (NIHSS) scores, and laboratory results like WBC count and D-dimer levels were associated with increased PSE risk. Tree-based methods like Random Forest, XGBoost, and LightGBM showed strong predictive performance, achieving an AUC of 0.99.
å›å½’åˆ†ææ˜¾ç¤ºï¼Œå¹¶å‘ç—‡ï¼Œå¦‚è„‘ç§¯æ°´ï¼Œè„‘ç–ï¼Œæ·±é™è„‰è¡€æ “å½¢æˆï¼Œä»¥åŠç‰¹å®šçš„å¤§è„‘åŒºåŸŸï¼ˆé¢å¶ï¼Œé¡¶å¶å’Œé¢å¶ï¼‰ï¼Œæ˜¾ç€æœ‰åŠ©äº PSEã€‚å¹´é¾„ã€æ€§åˆ«ã€NIH å’ä¸­é‡è¡¨ï¼ˆNIHSSï¼‰è¯„åˆ†å’Œå®éªŒå®¤æ£€æŸ¥ç»“æœï¼ˆå¦‚ WBC è®¡æ•°å’Œ D-äºŒèšä½“æ°´å¹³ï¼‰ç­‰å› ç´ ä¸ PSE é£é™©å¢åŠ ç›¸å…³ã€‚åŸºäºæ ‘çš„æ–¹æ³•ï¼Œå¦‚ Random Forestã€XGBoost å’Œ LightGBM æ˜¾ç¤ºå‡ºå¼ºå¤§çš„é¢„æµ‹æ€§èƒ½ï¼ŒAUC ä¸º 0.99ã€‚

### Conclusions:  ç»“è®ºï¼š
The model accurately predicts PSE risk, with tree-based models demonstrating superior performance. NIHSS score, WBC count, and D-dimer were identified as the most crucial predictors.
è¯¥æ¨¡å‹å‡†ç¡®é¢„æµ‹ PSE é£é™©ï¼ŒåŸºäºæ ‘çš„æ¨¡å‹è¡¨ç°å‡ºä¼˜è¶Šçš„ä¸Šçº§æ€§èƒ½ã€‚NIHSS è¯„åˆ†ã€WBC è®¡æ•°å’Œ D-äºŒèšä½“è¢«ç¡®å®šä¸ºæœ€é‡è¦çš„é¢„æµ‹å› å­ã€‚

### Funding:  èµ„é‡‘æ¥æºï¼š
The research is funded by Central University basic research young teachers and students research ability promotion sub-projec t(2023CDJYGRH-ZD06), and by Emergency Medicine Chongqing Key Laboratory Talent Innovation and development joint fund project (2024RCCX10).
æœ¬ç ”ç©¶å—ä¸­å¤®å¤§å­¦åŸºç¡€ç ”ç©¶é’å¹´å¸ˆç”Ÿç§‘ç ”èƒ½åŠ›æå‡å­é¡¹ç›®ï¼ˆ2023 CDJYGRH-ZD 06ï¼‰èµ„åŠ©ï¼Œå—æ€¥è¯ŠåŒ»å­¦é‡åº†å¸‚é‡ç‚¹å®éªŒå®¤äººæ‰åˆ›æ–°å‘å±•è”åˆåŸºé‡‘é¡¹ç›®ï¼ˆ2024 RCCX 10ï¼‰èµ„åŠ©ã€‚

### Research organism: None
ç ”ç©¶å¾®ç”Ÿç‰©ï¼š æ— 

## Introduction  ä»‹ç»
Stroke is the second leading cause of death worldwide, with an annual mortality of about 5.5 million, and is the leading cause of disability, accounting for 50% of cases globally (Feigin et al., 2017). Ischemic strokes make up approximately 80% of all stroke cases (Galovic et al., 2018; Krishnamurthi et al., 2013). PSE is a common complication, with studies showing that 3â€“30% of stroke patients develop epilepsy, which worsens their prognosis and quality of life (Zhao et al., 2018). PSE can exacerbate cognitive, psychiatric, and physical impairments caused by cerebrovascular disease and related conditions (Al-Sahli et al., 2023). The highest incidence of PSE occurs within the first year after an acute stroke, representing nearly half of all cases (Galovic et al., 2018). Therefore, early prediction and intervention for PSE, especially in ischemic strokes, are essential.
ä¸­é£æ˜¯å…¨çƒç¬¬äºŒå¤§æ­»äº¡åŸå› ï¼Œæ¯å¹´æ­»äº¡äººæ•°çº¦ä¸º 550 ä¸‡ï¼Œå¹¶ä¸”æ˜¯æ®‹ç–¾çš„ä¸»è¦åŸå› ï¼Œå å…¨çƒç—…ä¾‹çš„ 50%ï¼ˆ Feigin et al., 2017 ï¼‰ã€‚ç¼ºè¡€æ€§ä¸­é£çº¦å æ‰€æœ‰ä¸­é£ç—…ä¾‹çš„ 80%ï¼ˆ Galovic et al., 2018 ; Krishnamurthi et al., 2013 ï¼‰ã€‚PSE æ˜¯ä¸€ç§å¸¸è§çš„å¹¶å‘ç—‡ï¼Œç ”ç©¶è¡¨æ˜ 3-30%çš„ä¸­é£æ‚£è€…ä¼šå‘ç”Ÿç™«ç—«ï¼Œè¿™ä¼šå½±å“ä»–ä»¬çš„é¢„åå’Œç”Ÿæ´»è´¨é‡ï¼ˆ Zhao et al., 2018 ï¼‰ã€‚PSE å¯åŠ é‡è„‘è¡€ç®¡ç–¾ç—…å’Œç›¸å…³ç–¾ç—…å¼•èµ·çš„è®¤çŸ¥ã€ç²¾ç¥å’Œèº«ä½“æŸå®³ï¼ˆ Al-Sahli et al., 2023 ï¼‰ã€‚PSE çš„æœ€é«˜å‘ç—…ç‡å‘ç”Ÿåœ¨æ€¥æ€§å’ä¸­åçš„ç¬¬ä¸€å¹´å†…ï¼Œå æ‰€æœ‰ç—…ä¾‹çš„è¿‘ä¸€åŠï¼ˆ Galovic et al., 2018 ï¼‰ã€‚å› æ­¤ï¼Œæ—©æœŸé¢„æµ‹å’Œå¹²é¢„ PSEï¼Œå°¤å…¶æ˜¯ç¼ºè¡€æ€§å’ä¸­è‡³å…³é‡è¦ã€‚

Currently, most studies rely on clinical data to build statistical models using survival analysis, Cox regression (Galovic et al., 2018; Chen et al., 2018), and multiple linear regression (Merkler et al., 2018) to predict PSE. Last year, Lin et al., 2023 developed a radiomics-based model that outperformed conventional clinical models in predicting PSE related to intracerebral hemorrhage (ICH), suggesting that a combined radiomics-clinical model could improve individual risk assessment of PSE after the first ICH, facilitating early diagnosis and treatment. However, later research raised concerns about the use of radiomics, indicating the need for further investigation (Pszczolkowski and Law, 2023). Overall, research on PSE prediction remains limited, with most studies focusing on specific risk factors (Waafi et al., 2023; Herzig-NichtweiÃŸ et al., 2023; Lin et al., 2023; PitkÃ¤nen et al., 2016) and building basic models, rather than proposing more comprehensive and scientifically robust prediction models.
ç›®å‰ï¼Œå¤§å¤šæ•°ç ”ç©¶ä¾èµ–äºä¸´åºŠæ•°æ®ï¼Œä½¿ç”¨ç”Ÿå­˜åˆ†æã€è€ƒå…‹æ–¯å›å½’ï¼ˆ Galovic et al., 2018 ; Chen et al., 2018 ï¼‰å’Œå¤šå…ƒçº¿æ€§å›å½’ï¼ˆ Merkler et al., 2018 ï¼‰å»ºç«‹ç»Ÿè®¡æ¨¡å‹æ¥é¢„æµ‹ PSEã€‚å»å¹´ï¼Œ Lin et al., 2023 å¼€å‘äº†ä¸€ç§åŸºäºæ”¾å°„å­¦çš„æ¨¡å‹ï¼Œåœ¨é¢„æµ‹è„‘å‡ºè¡€ï¼ˆICHï¼‰ç›¸å…³ PSE æ–¹é¢ä¼˜äºä¼ ç»Ÿä¸´åºŠæ¨¡å‹ï¼Œè¡¨æ˜æ”¾å°„å­¦-ä¸´åºŠè”åˆæ¨¡å‹å¯ä»¥æ”¹å–„é¦–æ¬¡ ICH å PSE çš„ä¸ªä½“é£é™©è¯„ä¼°ï¼Œä¿ƒè¿›æ—©æœŸè¯Šæ–­å’Œæ²»ç–—ã€‚ç„¶è€Œï¼Œåæ¥çš„ç ”ç©¶å¯¹æ”¾å°„ç»„å­¦çš„ä½¿ç”¨æå‡ºäº†æ‹…å¿§ï¼Œè¡¨æ˜éœ€è¦è¿›ä¸€æ­¥ç ”ç©¶ï¼ˆ Pszczolkowski and Law, 2023 ï¼‰ã€‚æ€»ä½“è€Œè¨€ï¼Œå…³äº PSE é¢„æµ‹çš„ç ”ç©¶ä»ç„¶æœ‰é™ï¼Œå¤§å¤šæ•°ç ”ç©¶éƒ½é›†ä¸­åœ¨ç‰¹å®šçš„é£é™©å› ç´ ï¼ˆ Waafi et al., 2023 ; Herzig-NichtweiÃŸ et al., 2023 ; Lin et al., 2023 ; PitkÃ¤nen et al., 2016 ï¼‰å’Œå»ºç«‹åŸºæœ¬æ¨¡å‹ï¼Œè€Œä¸æ˜¯æå‡ºæ›´å…¨é¢å’Œç§‘å­¦å¯é çš„é¢„æµ‹æ¨¡å‹ã€‚

Machine learning has gained recognition as a powerful tool for developing medical models, due to its ability to process large datasets and handle complex information. It has been increasingly applied in neuroscience and clinical prediction (El Naamani et al., 2024; Lu et al., 2023; Daidone et al., 2024). Previous studies have used machine learning to explore post-stroke cognitive impairments (Lee et al., 2023), predict stroke and myocardial infarction risk in patients with large artery vasculitis (Lu et al., 2023), develop post-stroke depression models using liver function tests (Gong et al., 2023), and predict hematoma expansion in traumatic brain injury (TBI) (He et al., 2024). Machine learning models can automatically capture both linear and complex nonlinear relationships between variables, providing insights into how different factors contribute to the prediction targetâ€”something traditional statistical models struggle with. However, machine learning requires large datasets and is prone to overfitting when sample sizes are small. The quality and quantity of input data are critical for the algorithm to detect patterns and make accurate predictions.
æœºå™¨å­¦ä¹ å·²è¢«å…¬è®¤ä¸ºå¼€å‘åŒ»å­¦æ¨¡å‹çš„å¼ºå¤§å·¥å…·ï¼Œå› ä¸ºå®ƒèƒ½å¤Ÿå¤„ç†å¤§å‹æ•°æ®é›†å’Œå¤„ç†å¤æ‚ä¿¡æ¯ã€‚å®ƒå·²è¶Šæ¥è¶Šå¤šåœ°åº”ç”¨äºç¥ç»ç§‘å­¦å’Œä¸´åºŠé¢„æµ‹ï¼ˆ El Naamani et al., 2024 ; Lu et al., 2023 ; Daidone et al., 2024 ï¼‰ã€‚ä»¥å‰çš„ç ”ç©¶ä½¿ç”¨æœºå™¨å­¦ä¹ æ¥æ¢ç´¢ä¸­é£åè®¤çŸ¥éšœç¢ï¼ˆ Lee et al., 2023 ï¼‰ï¼Œé¢„æµ‹å¤§åŠ¨è„‰è¡€ç®¡ç‚æ‚£è€…çš„ä¸­é£å’Œå¿ƒè‚Œæ¢—æ­»é£é™©ï¼ˆ Lu et al., 2023 ï¼‰ï¼Œä½¿ç”¨è‚åŠŸèƒ½æµ‹è¯•å¼€å‘ä¸­é£åæŠ‘éƒæ¨¡å‹ï¼ˆ Gong et al., 2023 ï¼‰ï¼Œå¹¶é¢„æµ‹åˆ›ä¼¤æ€§è„‘æŸä¼¤ï¼ˆTBIï¼‰ä¸­çš„è¡€è‚¿æ‰©å¼ ï¼ˆ He et al., 2024 ï¼‰ã€‚æœºå™¨å­¦ä¹ æ¨¡å‹å¯ä»¥è‡ªåŠ¨æ•æ‰å˜é‡ä¹‹é—´çš„çº¿æ€§å’Œå¤æ‚çš„éçº¿æ€§å…³ç³»ï¼Œä»è€Œæ·±å…¥äº†è§£ä¸åŒå› ç´ å¯¹é¢„æµ‹ç›®æ ‡çš„å½±å“ï¼Œè€Œè¿™æ­£æ˜¯ä¼ ç»Ÿç»Ÿè®¡æ¨¡å‹éš¾ä»¥è§£å†³çš„é—®é¢˜ã€‚ç„¶è€Œï¼Œæœºå™¨å­¦ä¹ éœ€è¦å¤§å‹æ•°æ®é›†ï¼Œå¹¶ä¸”åœ¨æ ·æœ¬é‡è¾ƒå°æ—¶å®¹æ˜“è¿‡æ‹Ÿåˆã€‚ è¾“å…¥æ•°æ®çš„è´¨é‡å’Œæ•°é‡å¯¹äºç®—æ³•æ£€æµ‹æ¨¡å¼å’Œåšå‡ºå‡†ç¡®é¢„æµ‹è‡³å…³é‡è¦ã€‚

This study aims to identify key risk factors from features extracted from clinical records and test data of ischemic stroke patients. Using these features, a machine learning-based model will be developed to predict PSE. By leveraging early admission data, the goal is to automatically predict the likelihood of PSE occurrence, guiding clinical decision-making and patient care.
æœ¬ç ”ç©¶æ—¨åœ¨ä»ç¼ºè¡€æ€§å’ä¸­æ‚£è€…çš„ä¸´åºŠè®°å½•å’Œæµ‹è¯•æ•°æ®ä¸­æå–çš„ç‰¹å¾ä¸­è¯†åˆ«å…³é”®çš„å±é™©å› ç´ ã€‚ä½¿ç”¨è¿™äº›åŠŸèƒ½ï¼Œå°†å¼€å‘åŸºäºæœºå™¨å­¦ä¹ çš„æ¨¡å‹æ¥é¢„æµ‹ PSEã€‚é€šè¿‡åˆ©ç”¨æ—©æœŸå…¥é™¢æ•°æ®ï¼Œç›®æ ‡æ˜¯è‡ªåŠ¨é¢„æµ‹ PSE å‘ç”Ÿçš„å¯èƒ½æ€§ï¼ŒæŒ‡å¯¼ä¸´åºŠå†³ç­–å’Œæ‚£è€…æŠ¤ç†ã€‚

## Results  ç»“æœ
### Filling of missing data  ç¼ºå¤±æ•°æ®çš„å¡«è¡¥
Missing values were imputed using a Random Forest (RF) model, addressing one feature at a time. The imputed features included: Plt, WBC, RBC, HbA1c, CRP, TG, LDL, HDL, AST, ALT, bilirubin, albumin, urea, creatinine, BUA, PT, APTT, TT, INR, D-dimer, fibrinogen, CK, CK-MB, LDH, HBDH, IMA, lactate, anion gap, TCO2, and NIHSS (Figure 1).
ä½¿ç”¨éšæœºæ£®æ—ï¼ˆRFï¼‰æ¨¡å‹æ’è¡¥ç¼ºå¤±å€¼ï¼Œæ¯æ¬¡å¤„ç†ä¸€ä¸ªç‰¹å¾ã€‚æ’è¡¥ç‰¹å¾åŒ…æ‹¬ï¼šPltã€WBCã€RBCã€HbA 1cã€CRPã€TGã€LDLã€HDLã€ASTã€ALTã€èƒ†çº¢ç´ ã€ç™½è›‹ç™½ã€å°¿ç´ ã€è‚Œé…ã€BUAã€PTã€APTTã€TTã€INRã€D-äºŒèšä½“ã€çº¤ç»´è›‹ç™½åŸã€CKã€CK-MBã€LDHã€HBDHã€IMAã€ä¹³é…¸ã€é˜´ç¦»å­é—´éš™ã€TCO 2 å’Œ NIHSSï¼ˆ Figure 1 ï¼‰ã€‚
















### Characteristics of study participants    ç ”ç©¶å‚ä¸è€…çš„ç‰¹å¾
A total of 21,459 patients were included in the study. The training set comprised 15,021 patients, with a PSE incidence of 4.3%. The test set consisted of 6438 patients, also with a 4.3% incidence of PSE. An external validation cohort included 536 patients from three hospitals. Detailed statistical information on the clinical characteristics is presented in (Supplementary file 1).
å…±æœ‰ 21ï¼Œ459 åæ‚£è€…è¢«çº³å…¥ç ”ç©¶ã€‚è®­ç»ƒé›†åŒ…æ‹¬ 15ï¼Œ021 åæ‚£è€…ï¼ŒPSE å‘ç”Ÿç‡ä¸º 4.3%ã€‚æµ‹è¯•é›†åŒ…æ‹¬ 6438 ä¾‹æ‚£è€…ï¼ŒPSE çš„å‘ç”Ÿç‡ä¹Ÿä¸º 4.3%ã€‚å¤–éƒ¨éªŒè¯é˜Ÿåˆ—åŒ…æ‹¬æ¥è‡ªä¸‰å®¶åŒ»é™¢çš„ 536 ä¾‹æ‚£è€…ã€‚ä¸´åºŠç‰¹å¾çš„è¯¦ç»†ç»Ÿè®¡ä¿¡æ¯è§ï¼ˆ Supplementary file 1 ï¼‰ã€‚

Analysis indicated that patients with a higher likelihood of developing PSE had complications such as uremia, a history of DVT, atrial fibrillation, hyperuricemia, cerebral hernia, and hydrocephalus. Affected brain regions included the frontal, parietal, occipital, and temporal lobes, along with the cortex, subcortex, basal ganglia, and hypothalamus. General characteristics influencing risk included age, gender, and NIHSS. Laboratory indicators associated with a higher risk of PSE included WBC, HbA1c, CRP, TG, AST, ALT, bilirubin, urea, uric acid, APTT, PT, D-dimer, CK, CK-MB, LDH, HBDH, IMA, lactate, and anion gap. Significant p-values were also observed for fatty liver, coronary heart disease, hyperlipidemia, and HDL, with low or negative values linked to higher risks of secondary complications. Details of statistical, univariate, and multivariate regression analyses are provided in Supplementary file 1, Supplementary file 2, Supplementary file 3.
åˆ†æè¡¨æ˜ï¼Œå‘ç”Ÿ PSE å¯èƒ½æ€§è¾ƒé«˜çš„æ‚£è€…æœ‰å¹¶å‘ç—‡ï¼Œå¦‚å°¿æ¯’ç—‡ã€DVT ç—…å²ã€æˆ¿é¢¤ã€é«˜å°¿é…¸è¡€ç—‡ã€è„‘ç–å’Œè„‘ç§¯æ°´ã€‚å—å½±å“çš„å¤§è„‘åŒºåŸŸåŒ…æ‹¬é¢å¶ã€é¡¶å¶ã€æ•å¶å’Œé¢å¶ï¼Œä»¥åŠæ²¿ç€çš®è´¨ã€çš®è´¨ä¸‹ã€åŸºåº•ç¥ç»èŠ‚å’Œä¸‹ä¸˜è„‘ã€‚å½±å“é£é™©çš„ä¸€èˆ¬ç‰¹å¾åŒ…æ‹¬å¹´é¾„ã€æ€§åˆ«å’Œ NIHSSã€‚ä¸ PSE é£é™©è¾ƒé«˜ç›¸å…³çš„å®éªŒå®¤æŒ‡æ ‡åŒ…æ‹¬ WBCã€HbA 1cã€CRPã€TGã€ASTã€ALTã€èƒ†çº¢ç´ ã€å°¿ç´ ã€å°¿é…¸ã€APTTã€PTã€D-äºŒèšä½“ã€CKã€CK-MBã€LDHã€HBDHã€IMAã€ä¹³é…¸å’Œé˜´ç¦»å­é—´éš™ã€‚è„‚è‚ªè‚ã€å† å¿ƒç—…ã€é«˜è„‚è¡€ç—‡å’Œ HDL ä¹Ÿè§‚å¯Ÿåˆ°æ˜¾è‘—çš„ p å€¼ï¼Œä½å€¼æˆ–è´Ÿå€¼ä¸ç»§å‘æ€§å¹¶å‘ç—‡çš„é£é™©è¾ƒé«˜ç›¸å…³ã€‚ç»Ÿè®¡ã€å•å˜é‡å’Œå¤šå˜é‡å›å½’åˆ†æçš„è¯¦ç»†ä¿¡æ¯è§ Supplementary file 1 ã€ Supplementary file 2 ã€ Supplementary file 3 ã€‚

### Performance of machine learning models    æœºå™¨å­¦ä¹ æ¨¡å‹çš„æ€§èƒ½
Performance indicators for the machine learning models are summarized in Supplementary file 4. The ROC curves, calibration curve, and decision curve analysis (DCA) are shown in Figure 2. Tree-based models such as RF, XGBoost, and LightGBM demonstrated the highest AUC scores, outperforming other models. Among them, RF achieved the highest positive predictive value (PPV) at 0.864, which was the most significant metric in this study. Complex machine learning algorithms outperformed traditional logistic regression. The calibration curve showed a Brier score of 0.006, and DCA indicated strong practical value in clinical decision-making. In the external validation cohort, RF achieved a sensitivity of 0.91 and a PPV of 0.95, confirming its strong predictive capability.
æœºå™¨å­¦ä¹ æ¨¡å‹çš„æ€§èƒ½æŒ‡æ ‡æ€»ç»“åœ¨ Supplementary file 4 ä¸­ã€‚ROC æ›²çº¿ã€æ ¡å‡†æ›²çº¿å’Œå†³ç­–æ›²çº¿åˆ†æï¼ˆDCAï¼‰è§ Figure 2 ã€‚åŸºäºæ ‘çš„æ¨¡å‹ï¼Œå¦‚ RFï¼ŒXGBoost å’Œ LightGBM è¡¨ç°å‡ºæœ€é«˜çš„ AUC åˆ†æ•°ï¼Œä¼˜äºå…¶ä»–æ¨¡å‹ã€‚å…¶ä¸­ï¼ŒRF è¾¾åˆ°äº†æœ€é«˜çš„é˜³æ€§é¢„æµ‹å€¼ï¼ˆPPVï¼‰ï¼Œä¸º 0.864ï¼Œè¿™æ˜¯æœ¬ç ”ç©¶ä¸­æœ€é‡è¦çš„æŒ‡æ ‡ã€‚å¤æ‚çš„æœºå™¨å­¦ä¹ ç®—æ³•ä¼˜äºä¼ ç»Ÿçš„é€»è¾‘å›å½’ã€‚æ ¡å‡†æ›²çº¿æ˜¾ç¤º Brier è¯„åˆ†ä¸º 0.006ï¼ŒDCA åœ¨ä¸´åºŠå†³ç­–ä¸­å…·æœ‰å¾ˆå¼ºçš„å®ç”¨ä»·å€¼ã€‚åœ¨å¤–éƒ¨éªŒè¯é˜Ÿåˆ—ä¸­ï¼ŒRF å®ç°äº† 0.91 çš„çµæ•åº¦å’Œ 0.95 çš„ PPVï¼Œè¯å®äº†å…¶å¼ºå¤§çš„é¢„æµ‹èƒ½åŠ›ã€‚












### Analysis of SHAP risk factors    SHAP å±é™©å› ç´ åˆ†æ
Figure 3 presents SHAP values, individual decision attempts, and overall decision curves. Among general characteristics, females had a higher PSE rate. A higher NIHSS was associated with an increased incidence of PSE. Elevated WBC, D-dimer, CRP, AST, CK-MB, HbA1c, bilirubin, TCO2, and LDH levels at admission were linked to a greater likelihood of developing PSE. Conversely, lower levels of HBDH, Plt, and APTT were also associated with a higher risk of PSE. Specific brain regions did not have a significant individual effect on the outcome. Among complications, hypertension was more strongly associated with PSE development, while conditions such as coronary heart disease, diabetes, hyperlipidemia, and fatty liver were less likely to be related. A force plot for the first patient illustrated the influence of different features on the prediction. In this case, a prolonged APTT time contributed the most to PSE, followed by elevated AST levels, while a low NIHSS negatively impacted the final result. The decision plot aggregated model decisions to demonstrate how complex models generated their predictions.
Figure 3 æ˜¾ç¤º SHAP å€¼ã€å•ä¸ªå†³ç­–å°è¯•å’Œæ€»ä½“å†³ç­–æ›²çº¿ã€‚åœ¨ä¸€èˆ¬ç‰¹å¾ä¸­ï¼Œå¥³æ€§ PSE ç‡è¾ƒé«˜ã€‚è¾ƒé«˜çš„ NIHSS ä¸ PSE çš„å‘ç”Ÿç‡å¢åŠ ç›¸å…³ã€‚å…¥é™¢æ—¶ WBCã€D-äºŒèšä½“ã€CRPã€ASTã€CK-MBã€HbA 1cã€èƒ†çº¢ç´ ã€TCO 2 å’Œ LDH æ°´å¹³å‡é«˜ä¸å‘ç”Ÿ PSE çš„å¯èƒ½æ€§å¢åŠ ç›¸å…³ã€‚ç›¸åï¼ŒHBDHã€Plt å’Œ APTT æ°´å¹³è¾ƒä½ä¹Ÿä¸ PSE é£é™©è¾ƒé«˜ç›¸å…³ã€‚ç‰¹å®šçš„å¤§è„‘åŒºåŸŸå¯¹ç»“æœæ²¡æœ‰æ˜¾è‘—çš„ä¸ªä½“å½±å“ã€‚åœ¨å¹¶å‘ç—‡ä¸­ï¼Œé«˜è¡€å‹ä¸ PSE çš„å‘ç”Ÿæœ‰æ›´å¼ºçš„ç›¸å…³æ€§ï¼Œè€Œå† å¿ƒç—…ã€ç³–å°¿ç—…ã€é«˜è„‚è¡€ç—‡å’Œè„‚è‚ªè‚ç­‰ç–¾ç—…åˆ™ä¸å¤ªå¯èƒ½ç›¸å…³ã€‚ç¬¬ä¸€ä½æ‚£è€…çš„åŠ›å›¾è¯´æ˜äº†ä¸åŒç‰¹å¾å¯¹é¢„æµ‹çš„å½±å“ã€‚ åœ¨è¿™ç§æƒ…å†µä¸‹ï¼ŒAPTT æ—¶é—´å»¶é•¿å¯¹ PSE çš„è´¡çŒ®æœ€å¤§ï¼Œå…¶æ¬¡æ˜¯ AST æ°´å¹³å‡é«˜ï¼Œè€Œ NIHSS è¾ƒä½å¯¹æœ€ç»ˆç»“æœäº§ç”Ÿè´Ÿé¢å½±å“ã€‚å†³ç­–å›¾æ±‡æ€»äº†æ¨¡å‹å†³ç­–ï¼Œä»¥å±•ç¤ºå¤æ‚æ¨¡å‹å¦‚ä½•ç”Ÿæˆå…¶é¢„æµ‹ã€‚












## Discussion  è®¨è®º
The study utilized comprehensive clinical, imaging, and laboratory data from stroke patients to develop a predictive model using machine learning algorithms. The model achieved an AUC above 0.95, indicating more accurate predictions compared to traditional statistical methods. Tree-based ensemble models demonstrated superior predictive performance, particularly when handling large datasets with high-dimensional features.
è¯¥ç ”ç©¶åˆ©ç”¨ä¸­é£æ‚£è€…çš„ç»¼åˆä¸´åºŠï¼Œæˆåƒå’Œå®éªŒå®¤æ•°æ®ï¼Œä½¿ç”¨æœºå™¨å­¦ä¹ ç®—æ³•å¼€å‘é¢„æµ‹æ¨¡å‹ã€‚è¯¥æ¨¡å‹çš„ AUC é«˜äº 0.95ï¼Œè¡¨æ˜ä¸ä¼ ç»Ÿç»Ÿè®¡æ–¹æ³•ç›¸æ¯”é¢„æµ‹æ›´å‡†ç¡®ã€‚åŸºäºæ ‘çš„é›†æˆæ¨¡å‹è¡¨ç°å‡ºä¸Šçº§é¢„æµ‹æ€§èƒ½ï¼Œç‰¹åˆ«æ˜¯åœ¨å¤„ç†å…·æœ‰é«˜ç»´ç‰¹å¾çš„å¤§å‹æ•°æ®é›†æ—¶ã€‚

During the modeling process, the extreme imbalance between negative and positive samples was addressed using the SMOTEENN technique, which improved model performance. SHAP analysis was conducted to assess model interpretability and identify the importance of different features.
åœ¨å»ºæ¨¡è¿‡ç¨‹ä¸­ï¼Œä½¿ç”¨ SMOTEENN æŠ€æœ¯è§£å†³äº†æ­£è´Ÿæ ·æœ¬ä¹‹é—´çš„æç«¯ä¸å¹³è¡¡ï¼Œä»è€Œæé«˜äº†æ¨¡å‹æ€§èƒ½ã€‚è¿›è¡Œ SHAP åˆ†æä»¥è¯„ä¼°æ¨¡å‹çš„å¯è§£é‡Šæ€§å¹¶ç¡®å®šä¸åŒç‰¹å¾çš„é‡è¦æ€§ã€‚

According to the statistical results, age and NIHSS were treated as continuous variables. The results show that female patients, older individuals, and those with higher NIHSS were more likely to develop PSE, consistent with recent studies. Higher NIHSS, indicating more severe strokes, significantly increased the risk of complications, ranking second only to WBC and D-dimer in predictive importance (Al-Sahli et al., 2023; Lin et al., 2021; Waafi et al., 2023; ZÃ¶llner et al., 2020). However, there are differing perspectives regarding the effect of age. Some studies (Al-Sahli et al., 2023; Yamada et al., 2020) suggest that age below 65 is a high-risk factor, which aligns with this findings, while other studies (Lidetu and Zewdu, 2023) indicate that advanced age is the key factor. Yamada et al., 2020 supported the results, showing that female patients have a higher risk of complications, while (Waafi et al., 2023) reported that male patients are 3.325 times more likely to develop complications, contradicting these results.
æ ¹æ®ç»Ÿè®¡ç»“æœï¼Œå¹´é¾„å’Œ NIHSS è¢«è§†ä¸ºè¿ç»­å˜é‡ã€‚ç»“æœè¡¨æ˜ï¼Œå¥³æ€§æ‚£è€…ã€è€å¹´äººå’Œ NIHSS è¾ƒé«˜çš„æ‚£è€…æ›´æœ‰å¯èƒ½å‘ç”Ÿ PSEï¼Œè¿™ä¸æœ€è¿‘çš„ç ”ç©¶ä¸€è‡´ã€‚NIHSS è¯„åˆ†è¶Šé«˜ï¼Œè¡¨æ˜å’ä¸­è¶Šä¸¥é‡ï¼Œå¹¶å‘ç—‡é£é™©æ˜¾è‘—å¢åŠ ï¼Œåœ¨é¢„æµ‹é‡è¦æ€§æ–¹é¢ä»…æ¬¡äº WBC å’Œ D-äºŒèšä½“ï¼ˆ Al-Sahli et al., 2023 ; Lin et al., 2021 ; Waafi et al., 2023 ; ZÃ¶llner et al., 2020 ï¼‰ã€‚ç„¶è€Œï¼Œå¯¹äºå¹´é¾„çš„å½±å“æœ‰ä¸åŒçš„çœ‹æ³•ã€‚ä¸€äº›ç ”ç©¶ï¼ˆ Al-Sahli et al., 2023 ; Yamada et al., 2020 ï¼‰è¡¨æ˜ï¼Œ65 å²ä»¥ä¸‹æ˜¯ä¸€ä¸ªé«˜é£é™©å› ç´ ï¼Œè¿™ä¸è¿™ä¸€å‘ç°ä¸€è‡´ï¼Œè€Œå…¶ä»–ç ”ç©¶ï¼ˆ Lidetu and Zewdu, 2023 ï¼‰è¡¨æ˜ï¼Œé«˜é¾„æ˜¯å…³é”®å› ç´ ã€‚ Yamada et al., 2020 æ”¯æŒè¯¥ç»“æœï¼Œè¡¨æ˜å¥³æ€§æ‚£è€…æœ‰æ›´é«˜çš„å¹¶å‘ç—‡é£é™©ï¼Œè€Œï¼ˆ Waafi et al., 2023 ï¼‰æŠ¥å‘Šç§°ç”·æ€§æ‚£è€…å‘ç”Ÿå¹¶å‘ç—‡çš„å¯èƒ½æ€§æ˜¯ç”·æ€§æ‚£è€…çš„ 3.325 å€ï¼Œä¸è¿™äº›ç»“æœç›¸çŸ›ç›¾ã€‚

Previous research indicates that patients with diabetes, dyslipidemia, hypertension, depression, or dementia are at higher risk of developing vascular epilepsy (PitkÃ¤nen et al., 2016). In this study, statistical analysis and multiple ML models examined the relationship between comorbidities and complications. Patients with coronary heart disease, diabetes, fatty liver, hyperlipidemia, or large artery stenosis or plaques (CCA and ICA) were found to be less likely to develop epilepsy. According to the TOAST classification, ischemic stroke is divided into five categories: large artery atherosclerosis, cardioembolism, small vessel occlusion, other determined etiology, and undetermined etiology. Patients with multiple comorbidities often fall into the large artery atherosclerosis and cardioembolism categories, which are more clearly defined and easier to treat, resulting in a lower likelihood of epilepsy. In contrast, strokes of undetermined etiology tend to have worse prognoses and a higher likelihood of leading to epilepsy. Among patients with diabetes, higher HbA1c levels indicate poor blood sugar control and a higher risk of complications. Better blood sugar control was associated with a lower overall risk of developing complications.
å…ˆå‰çš„ç ”ç©¶è¡¨æ˜ï¼Œç³–å°¿ç—…ã€è¡€è„‚å¼‚å¸¸ã€é«˜è¡€å‹ã€æŠ‘éƒç—‡æˆ–ç—´å‘†ç—‡æ‚£è€…å‘ç”Ÿè¡€ç®¡æ€§ç™«ç—«çš„é£é™©è¾ƒé«˜ï¼ˆ PitkÃ¤nen et al., 2016 ï¼‰ã€‚åœ¨è¿™é¡¹ç ”ç©¶ä¸­ï¼Œç»Ÿè®¡åˆ†æå’Œå¤šä¸ª ML æ¨¡å‹æ£€æŸ¥äº†åˆå¹¶ç—‡å’Œå¹¶å‘ç—‡ä¹‹é—´çš„å…³ç³»ã€‚æ‚£æœ‰å† å¿ƒç—…ã€ç³–å°¿ç—…ã€è„‚è‚ªè‚ã€é«˜è„‚è¡€ç—‡æˆ–å¤§åŠ¨è„‰ç‹­çª„æˆ–æ–‘å—ï¼ˆCCA å’Œä¼Šå¡ï¼‰çš„æ‚£è€…å‘ç”Ÿç™«ç—«çš„å¯èƒ½æ€§è¾ƒä½ã€‚æ ¹æ®åå¸åˆ†ç±»ï¼Œç¼ºè¡€æ€§å’ä¸­åˆ†ä¸ºäº”ç±»ï¼šå¤§åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ã€å¿ƒæºæ€§æ “å¡ã€å°è¡€ç®¡é—­å¡ã€å…¶ä»–ç¡®å®šçš„ç—…å› å’Œæœªç¡®å®šçš„ç—…å› ã€‚æ‚£æœ‰å¤šç§åˆå¹¶ç—‡çš„æ‚£è€…é€šå¸¸å±äºå¤§åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–å’Œå¿ƒæºæ€§æ “å¡ç±»åˆ«ï¼Œè¿™äº›ç±»åˆ«å®šä¹‰æ›´æ˜ç¡®ï¼Œæ›´å®¹æ˜“æ²»ç–—ï¼Œå¯¼è‡´ç™«ç—«çš„å¯èƒ½æ€§è¾ƒä½ã€‚ ç›¸æ¯”ä¹‹ä¸‹ï¼Œç—…å› ä¸æ˜çš„ä¸­é£å¾€å¾€æœ‰æ›´ä¸¥é‡çš„ä¸­é£å’Œæ›´é«˜çš„å¯èƒ½æ€§å¯¼è‡´ç™«ç—«ã€‚åœ¨ç³–å°¿ç—…æ‚£è€…ä¸­ï¼Œè¾ƒé«˜çš„ HbA1c æ°´å¹³è¡¨æ˜è¡€ç³–æ§åˆ¶ä¸è‰¯å’Œå¹¶å‘ç—‡é£é™©è¾ƒé«˜ã€‚æ›´å¥½çš„è¡€ç³–æ§åˆ¶ä¸æ›´ä½çš„å¹¶å‘ç—‡å‘ç”Ÿé£é™©ç›¸å…³ã€‚

Lekoubou et al., 2023 reported that cortical infarction is more likely to lead to epilepsy in patients hospitalized with anterior circulation ischemic stroke. Lin et al., 2023 also found that factors such as cortical involvement and intracerebral hemorrhage volume increase the likelihood of PSE, aligning with the statistical result findings. Al-Sahli et al. suggested that cortical brain injury and large-area lesions elevate the risk of PSE (Al-Sahli et al., 2023; Yamada et al., 2020). According to the statistical results, both cortical and subcortical involvement were associated with an increased likelihood of PSE, but these regions had a smaller influence compared to other features and were not selected in LASSO regression.
Lekoubou et al., 2023 æŠ¥å‘Šç§°ï¼Œåœ¨å› å‰å¾ªç¯ç¼ºè¡€æ€§å’ä¸­ä½é™¢çš„æ‚£è€…ä¸­ï¼Œçš®è´¨æ¢—æ­»æ›´å¯èƒ½å¯¼è‡´ç™«ç—«ã€‚ Lin et al., 2023 è¿˜å‘ç°ï¼Œçš®è´¨å—ç´¯å’Œè„‘å†…å‡ºè¡€é‡ç­‰å› ç´ å¢åŠ äº† PSE çš„å¯èƒ½æ€§ï¼Œä¸ç»Ÿè®¡ç»“æœå‘ç°ä¸€è‡´ã€‚Al-Sahli ç­‰äººè®¤ä¸ºçš®è´¨è„‘æŸä¼¤å’Œå¤§é¢ç§¯ç—…å˜ä¼šå¢åŠ  PSE çš„é£é™©ï¼ˆ Al-Sahli et al., 2023 ; Yamada et al., 2020 ï¼‰ã€‚æ ¹æ®ç»Ÿè®¡ç»“æœï¼Œçš®è´¨å’Œçš®è´¨ä¸‹å—ç´¯å‡ä¸ PSE çš„å¯èƒ½æ€§å¢åŠ ç›¸å…³ï¼Œä½†ä¸å…¶ä»–ç‰¹å¾ç›¸æ¯”ï¼Œè¿™äº›åŒºåŸŸçš„å½±å“è¾ƒå°ï¼Œå¹¶ä¸”æœªåœ¨ LASSO å›å½’ä¸­é€‰æ‹©ã€‚

Previous studies have identified acute infection as a risk factor for ischemic stroke (Bova et al., 1996). CRP, which reflects inflammation levels, is an independent prognostic factor (Di Napoli et al., 2001). Both regression and SHAP analysis of the results indicated that WBC had a significant impact among routine blood test parameters, even surpassing NIHSS in SHAP analysis. A high WBC may indicate severe inflammation or infection, as well as increased blood viscosity, predisposing patients to secondary complications. High RBC and low Plt counts were also associated with an increased risk of complications.
å…ˆå‰çš„ç ”ç©¶å·²ç»ç¡®å®šæ€¥æ€§æ„ŸæŸ“æ˜¯ç¼ºè¡€æ€§å’ä¸­çš„é£é™©å› ç´ ï¼ˆ Bova et al., 1996 ï¼‰ã€‚åæ˜ ç‚ç—‡æ°´å¹³çš„ CRP æ˜¯ä¸€ä¸ªç‹¬ç«‹çš„é¢„åå› ç´ ï¼ˆ Di Napoli et al., 2001 ï¼‰ã€‚å›å½’åˆ†æå’Œ SHAP åˆ†æç»“æœå‡è¡¨æ˜ï¼ŒWBC åœ¨è¡€å¸¸è§„æŒ‡æ ‡ä¸­æœ‰æ˜¾è‘—å½±å“ï¼Œåœ¨ SHAP åˆ†æä¸­ç”šè‡³è¶…è¿‡ NIHSSã€‚é«˜ WBC å¯èƒ½è¡¨æ˜ä¸¥é‡çš„ç‚ç—‡æˆ–æ„ŸæŸ“ï¼Œä»¥åŠè¡€æ¶²ç²˜åº¦å¢åŠ ï¼Œä½¿æ‚£è€…æ˜“äºç»§å‘å¹¶å‘ç—‡ã€‚é«˜ RBC å’Œä½ Plt è®¡æ•°ä¹Ÿä¸å¹¶å‘ç—‡é£é™©å¢åŠ ç›¸å…³ã€‚

A large-scale study on Chinese individuals found a negative correlation between plasma HDL and the risk of ischemic stroke, a weak positive correlation between TG levels and stroke risk, and a strong correlation between LDL and apolipoprotein B levels (Sun et al., 2019). High HDL levels are linked to better prognosis (Bandeali and Farmer, 2012). The data analysis and model interpretation results align with these findings, showing that high LDL, low HDL, and elevated TG levels are more likely to result in PSE. This can be explained by high cholesterol and TG levels increasing blood viscosity and contributing to vascular sclerosis, promoting clot formation (PitkÃ¤nen et al., 2016; Gasparini et al., 2022; Abraira et al., 2020). Higher D-dimer levels indicate more significant brain tissue damage, increasing the likelihood of PSE. In general, lower APTT and fibrinogen levels are associated with higher PSE risk, while INR, PT, and TT have smaller impacts. Among liver function indicators, AST had the greatest influence on PSE. High AST, low ALT, and low albumin levels also had some impact. Ding et al., 2023 reported that liver enzyme subgroups defined by ALT and AST were linked to higher risks of adverse outcomes, consistent with this findings.
ä¸€é¡¹é’ˆå¯¹ä¸­å›½ä¸ªä½“çš„å¤§è§„æ¨¡ç ”ç©¶å‘ç°ï¼Œè¡€æµ† HDL ä¸ç¼ºè¡€æ€§å’ä¸­é£é™©å‘ˆè´Ÿç›¸å…³ï¼ŒTG æ°´å¹³ä¸å’ä¸­é£é™©å‘ˆå¼±æ­£ç›¸å…³ï¼ŒLDL ä¸è½½è„‚è›‹ç™½ B æ°´å¹³å‘ˆå¼ºç›¸å…³ï¼ˆ Sun et al., 2019 ï¼‰ã€‚é«˜ HDL æ°´å¹³ä¸æ›´å¥½çš„é¢„åæœ‰å…³ï¼ˆ Bandeali and Farmer, 2012 ï¼‰ã€‚æ•°æ®åˆ†æå’Œæ¨¡å‹è§£é‡Šç»“æœä¸è¿™äº›å‘ç°ä¸€è‡´ï¼Œè¡¨æ˜é«˜ LDLï¼Œä½ HDL å’Œ TG æ°´å¹³å‡é«˜æ›´å¯èƒ½å¯¼è‡´ PSEã€‚è¿™å¯ä»¥è§£é‡Šä¸ºé«˜èƒ†å›ºé†‡å’Œ TG æ°´å¹³å¢åŠ è¡€æ¶²ç²˜åº¦ï¼Œå¹¶æœ‰åŠ©äºè¡€ç®¡ç¡¬åŒ–ï¼Œä¿ƒè¿›å‡å—å½¢æˆï¼ˆ PitkÃ¤nen et al., 2016 ; Gasparini et al., 2022 ; Abraira et al., 2020 ï¼‰ã€‚è¾ƒé«˜çš„ D-äºŒèšä½“æ°´å¹³è¡¨æ˜æ›´ä¸¥é‡çš„è„‘ç»„ç»‡æŸä¼¤ï¼Œå¢åŠ äº† PSE çš„å¯èƒ½æ€§ã€‚ä¸€èˆ¬è€Œè¨€ï¼Œè¾ƒä½çš„ APTT å’Œçº¤ç»´è›‹ç™½åŸæ°´å¹³ä¸è¾ƒé«˜çš„ PSE é£é™©ç›¸å…³ï¼Œè€Œ INRã€PT å’Œ TT çš„å½±å“è¾ƒå°ã€‚è‚åŠŸèƒ½æŒ‡æ ‡ä¸­ï¼ŒAST å¯¹ PSE çš„å½±å“æœ€å¤§ã€‚ é«˜ ASTã€ä½ ALT å’Œä½ç™½è›‹ç™½æ°´å¹³ä¹Ÿæœ‰ä¸€å®šå½±å“ã€‚ Ding et al., 2023 æŠ¥å‘Šç§°ï¼Œç”± ALT å’Œ AST å®šä¹‰çš„è‚é…¶äºšç»„ä¸ä¸è‰¯ç»“å±€çš„è¾ƒé«˜é£é™©ç›¸å…³ï¼Œä¸è¯¥ç»“æœä¸€è‡´ã€‚

Studies have shown that renal function biomarkers such as urinary microalbumin, cystatin C, and creatinine are associated with higher stroke recurrence rates and poorer prognosis (Ding et al., 2023). In the light of statistical results, low urea levels and high uric acid levels had a negative impact (Zhang et al., 2023; Wang et al., 2019; Wang et al., 2021). Elevated uric acid at admission was positively associated with PSE, although patients with a prior diagnosis of hyperuricemia were less likely to develop epilepsy. Since uric acid acts as a strong antioxidant and has neuroprotective properties (Ng et al., 2017), patients with normal liver and kidney function and mild hyperuricemia may exhibit greater resilience in emergencies (Amaro et al., 2011). However, excessively high uric acid levels suggest metabolic disorders and poor liver and kidney function, which are linked to a poor prognosis.
ç ”ç©¶è¡¨æ˜ï¼Œè‚¾åŠŸèƒ½ç”Ÿç‰©æ ‡å¿—ç‰©å¦‚å°¿å¾®é‡ç™½è›‹ç™½ã€èƒ±æŠ‘ç´  C å’Œè‚Œé…ä¸è¾ƒé«˜çš„å’ä¸­å¤å‘ç‡å’Œè¾ƒå·®çš„é¢„åç›¸å…³ï¼ˆ Ding et al., 2023 ï¼‰ã€‚æ ¹æ®ç»Ÿè®¡ç»“æœï¼Œä½å°¿ç´ æ°´å¹³å’Œé«˜å°¿é…¸æ°´å¹³å…·æœ‰è´Ÿé¢å½±å“ï¼ˆ Zhang et al., 2023 ; Wang et al., 2019 ; Wang et al., 2021 ï¼‰ã€‚å…¥é™¢æ—¶å°¿é…¸å‡é«˜ä¸ PSE å‘ˆæ­£ç›¸å…³ï¼Œå°½ç®¡å…ˆå‰è¯Šæ–­ä¸ºé«˜å°¿é…¸è¡€ç—‡çš„æ‚£è€…ä¸å¤ªå¯èƒ½å‘å±•ä¸ºç™«ç—«ã€‚ç”±äºå°¿é…¸ä½œä¸ºä¸€ç§å¼ºæŠ—æ°§åŒ–å‰‚ï¼Œå…·æœ‰ç¥ç»ä¿æŠ¤ä½œç”¨ï¼ˆ Ng et al., 2017 ï¼‰ï¼Œè‚è‚¾åŠŸèƒ½æ­£å¸¸å’Œè½»åº¦é«˜å°¿é…¸è¡€ç—‡çš„æ‚£è€…åœ¨ç´§æ€¥æƒ…å†µä¸‹å¯èƒ½è¡¨ç°å‡ºæ›´å¤§çš„å¼¹æ€§ï¼ˆ Amaro et al., 2011 ï¼‰ã€‚ç„¶è€Œï¼Œè¿‡é«˜çš„å°¿é…¸æ°´å¹³æç¤ºä»£è°¢ç´Šä¹±å’Œè‚è‚¾åŠŸèƒ½ä¸è‰¯ï¼Œè¿™ä¸é¢„åä¸è‰¯æœ‰å…³ã€‚

When stroke patients are admitted, cardiac enzyme tests are often performed to rule out myocardial ischemia. However, studies have shown that elevated CK-MB in stroke patients may not be solely heart-related (Ay et al., 2002). Cardiac enzymes are important prognostic indicators (Liu et al., 2014; Zeng et al., 2021) and have been incorporated into stroke scores (Hijazi et al., 2016). Some studies have reported a higher incidence of abnormal serum cardiac enzyme levels in the acute phase of stroke. Although these abnormalities are not related to stroke type, they are associated with stroke severity, with patients exhibiting consciousness disorders having a significantly higher incidence of abnormal cardiac enzymes than those without such disorders (Zheng Yuan-Hui and Jian, 2009). According to the statistical and SHAP results, CK, CK-MB, and IMA in the cardiac enzyme profile demonstrated significant impact and high predictive value, though further research is needed to understand the specific mechanisms involved (Ng et al., 2017).
å½“ä¸­é£æ‚£è€…å…¥é™¢æ—¶ï¼Œç»å¸¸è¿›è¡Œå¿ƒè‚Œé…¶è¯•éªŒä»¥æ’é™¤å¿ƒè‚Œç¼ºè¡€ã€‚ç„¶è€Œï¼Œç ”ç©¶è¡¨æ˜ï¼Œä¸­é£æ‚£è€…çš„ CK-MB å‡é«˜å¯èƒ½ä¸ä»…ä»…ä¸å¿ƒè„ç›¸å…³ï¼ˆ Ay et al., 2002 ï¼‰ã€‚å¿ƒè‚Œé…¶æ˜¯é‡è¦çš„é¢„åæŒ‡æ ‡ï¼ˆ Liu et al., 2014 ; Zeng et al., 2021 ï¼‰ï¼Œå·²çº³å…¥å’ä¸­è¯„åˆ†ï¼ˆ Hijazi et al., 2016 ï¼‰ã€‚ä¸€äº›ç ”ç©¶æŠ¥é“äº†ä¸­é£æ€¥æ€§æœŸè¡€æ¸…å¿ƒè‚Œé…¶æ°´å¹³å¼‚å¸¸çš„å‘ç”Ÿç‡è¾ƒé«˜ã€‚å°½ç®¡è¿™äº›å¼‚å¸¸ä¸å’ä¸­ç±»å‹æ— å…³ï¼Œä½†ä¸å’ä¸­ä¸¥é‡ç¨‹åº¦ç›¸å…³ï¼Œè¡¨ç°å‡ºæ„è¯†éšœç¢çš„æ‚£è€…ä¸æ— æ„è¯†éšœç¢çš„æ‚£è€…ç›¸æ¯”ï¼Œå¿ƒè‚Œé…¶å¼‚å¸¸çš„å‘ç”Ÿç‡æ˜¾è‘—æ›´é«˜ï¼ˆ Zheng Yuan-Hui and Jian, 2009 ï¼‰ã€‚æ ¹æ®ç»Ÿè®¡å’Œ SHAP ç»“æœï¼Œå¿ƒè‚Œé…¶è°±ä¸­çš„ CKã€CK-MB å’Œ IMA è¡¨ç°å‡ºæ˜¾è‘—å½±å“å’Œé«˜é¢„æµ‹ä»·å€¼ï¼Œä½†éœ€è¦è¿›ä¸€æ­¥ç ”ç©¶ä»¥äº†è§£æ‰€æ¶‰åŠçš„å…·ä½“æœºåˆ¶ï¼ˆ Ng et al., 2017 ï¼‰ã€‚

Despite incorporating extensive clinical, imaging, and laboratory data to build more accurate prediction models using machine learning algorithms, surpassing traditional statistical methods, there were several limitations in the modeling process.
å°½ç®¡ä½¿ç”¨æœºå™¨å­¦ä¹ ç®—æ³•ç»“åˆäº†å¤§é‡çš„ä¸´åºŠã€æˆåƒå’Œå®éªŒå®¤æ•°æ®æ¥æ„å»ºæ›´å‡†ç¡®çš„é¢„æµ‹æ¨¡å‹ï¼Œè¶…è¶Šäº†ä¼ ç»Ÿçš„ç»Ÿè®¡æ–¹æ³•ï¼Œä½†å»ºæ¨¡è¿‡ç¨‹ä¸­ä»å­˜åœ¨ä¸€äº›å±€é™æ€§ã€‚

Although the current study offers valuable insights, the dataset may not be fully representative, and the modelâ€™s generalizability requires further evaluation. The data were collected from multiple tertiary hospitals and included over 20,000 cases, but earlier data were lost due to hospital system upgrades. Consequently, the dataset primarily reflects patients diagnosed within the past five years and is predominantly from the Chongqing region, which may limit the modelâ€™s applicability to other geographic areas.
å°½ç®¡ç›®å‰çš„ç ”ç©¶æä¾›äº†æœ‰ä»·å€¼çš„è§è§£ï¼Œä½†æ•°æ®é›†å¯èƒ½ä¸å…·æœ‰å……åˆ†çš„ä»£è¡¨æ€§ï¼Œæ¨¡å‹çš„æ™®éæ€§éœ€è¦è¿›ä¸€æ­¥è¯„ä¼°ã€‚è¿™äº›æ•°æ®æ˜¯ä»å¤šå®¶ä¸‰çº§åŒ»é™¢æ”¶é›†çš„ï¼ŒåŒ…æ‹¬20ï¼Œ000å¤šä¾‹ç—…ä¾‹ï¼Œä½†ç”±äºåŒ»é™¢ç³»ç»Ÿå‡çº§ï¼Œæ—©æœŸæ•°æ®ä¸¢å¤±ã€‚å› æ­¤ï¼Œè¯¥æ•°æ®é›†ä¸»è¦åæ˜ äº†è¿‡å»äº”å¹´å†…è¯Šæ–­çš„æ‚£è€…ï¼Œå¹¶ä¸”ä¸»è¦æ¥è‡ªé‡åº†åœ°åŒºï¼Œè¿™å¯èƒ½é™åˆ¶äº†è¯¥æ¨¡å‹å¯¹å…¶ä»–åœ°ç†åŒºåŸŸçš„é€‚ç”¨æ€§ã€‚

Additionally, the retrospective nature of the study led to the absence of some important predictive indicators. Several potentially valuable features, such as hemorheology, thromboelastography, and hormone levels, were missing and had to be excluded, potentially affecting the modelâ€™s accuracy. Including these features could further enhance the modelâ€™s predictive power.
æ­¤å¤–ï¼Œè¯¥ç ”ç©¶çš„å›é¡¾æ€§æ€§è´¨å¯¼è‡´ç¼ºä¹ä¸€äº›é‡è¦çš„é¢„æµ‹æŒ‡æ ‡ã€‚å‡ ä¸ªæ½œåœ¨çš„æœ‰ä»·å€¼çš„ç‰¹å¾ï¼Œå¦‚è¡€æ¶²æµå˜å­¦ï¼Œè¡€æ “å¼¹æ€§æè®°æœ¯å’Œæ¿€ç´ æ°´å¹³ï¼Œç¼ºå¤±ï¼Œä¸å¾—ä¸è¢«æ’é™¤ï¼Œå¯èƒ½å½±å“æ¨¡å‹çš„å‡†ç¡®æ€§ã€‚åŒ…æ‹¬è¿™äº›ç‰¹å¾å¯ä»¥è¿›ä¸€æ­¥å¢å¼ºæ¨¡å‹çš„é¢„æµ‹èƒ½åŠ›ã€‚

To improve the model, it would be beneficial to incorporate additional data beyond baseline patient characteristics. The current analysis mainly used results from the initial examination upon admission, without fully leveraging information from subsequent exams. Future research could employ recurrent neural networks to extract features from the entire sequence of examinations more comprehensively.
ä¸ºäº†æ”¹è¿›æ¨¡å‹ï¼Œå°†åŸºçº¿æ‚£è€…ç‰¹å¾ä¹‹å¤–çš„å…¶ä»–æ•°æ®çº³å…¥å°†æ˜¯æœ‰ç›Šçš„ã€‚ç›®å‰çš„åˆ†æä¸»è¦ä½¿ç”¨å…¥å­¦æ—¶çš„åˆæ­¥æ£€æŸ¥ç»“æœï¼Œè€Œæ²¡æœ‰å……åˆ†åˆ©ç”¨åç»­æ£€æŸ¥çš„ä¿¡æ¯ã€‚æœªæ¥çš„ç ”ç©¶å¯ä»¥ä½¿ç”¨é€’å½’ç¥ç»ç½‘ç»œæ›´å…¨é¢åœ°ä»æ•´ä¸ªæ£€æŸ¥åºåˆ—ä¸­æå–ç‰¹å¾ã€‚

To strengthen this study further, data standardization should be improved, and the number of cases and key indicators should continue to grow. Additionally, exploring more advanced scientific methods, such as deep learning, and utilizing all available data could enhance prediction accuracy.
ä¸ºè¿›ä¸€æ­¥åŠ å¼ºè¿™ä¸€ç ”ç©¶ï¼Œåº”æé«˜æ•°æ®æ ‡å‡†åŒ–ï¼Œå¹¶åº”ç»§ç»­å¢åŠ æ¡ˆä¾‹å’Œå…³é”®æŒ‡æ ‡çš„æ•°é‡ã€‚æ­¤å¤–ï¼Œæ¢ç´¢æ›´å…ˆè¿›çš„ç§‘å­¦æ–¹æ³•ï¼Œå¦‚æ·±åº¦å­¦ä¹ ï¼Œå¹¶åˆ©ç”¨æ‰€æœ‰å¯ç”¨çš„æ•°æ®å¯ä»¥æé«˜é¢„æµ‹çš„å‡†ç¡®æ€§ã€‚


## Materials and methods  ææ–™å’Œæ–¹æ³•
### Research patients  ç ”ç©¶æ‚£è€…
This study retrospectively included all stroke patients admitted to Chongqing Emergency Center between June 2017 and June 2022 to develop the prediction model. Data from three external validation centersâ€”Qianjiang Central Hospital, Bishan District Peopleâ€™s Hospital, and Yubei District Traditional Chinese Medicine Hospitalâ€”were collected between July 2022 and July 2023 to validate and evaluate the model externally. The external validation cohort focused on collecting positive cases to accurately test the modelâ€™s ability to identify them.
æœ¬ç ”ç©¶å›é¡¾æ€§çº³å…¥äº†2017å¹´6æœˆè‡³2022å¹´6æœˆé‡åº†å¸‚æ€¥æ•‘ä¸­å¿ƒæ”¶æ²»çš„æ‰€æœ‰è„‘å’ä¸­æ‚£è€…ï¼Œä»¥å»ºç«‹é¢„æµ‹æ¨¡å‹ã€‚åœ¨2022å¹´7æœˆè‡³2023å¹´7æœˆæœŸé—´ï¼Œæ”¶é›†äº†ä¸‰å®¶å¤–éƒ¨éªŒè¯ä¸­å¿ƒ--é»”æ±ŸåŒºä¸­å¿ƒåŒ»é™¢ã€ç’§å±±åŒºäººæ°‘åŒ»é™¢ã€æ¸åŒ—åŒºä¸­åŒ»é™¢çš„æ•°æ®ï¼Œå¯¹æ¨¡å‹è¿›è¡Œå¤–éƒ¨éªŒè¯å’Œè¯„ä¼°ã€‚å¤–éƒ¨éªŒè¯é˜Ÿåˆ—ä¸“æ³¨äºæ”¶é›†é˜³æ€§æ¡ˆä¾‹ï¼Œä»¥å‡†ç¡®æµ‹è¯•æ¨¡å‹è¯†åˆ«å®ƒä»¬çš„èƒ½åŠ›ã€‚

Inclusion criteria included: (1) Patients aged 18â€“90 years at admission; (2) Diagnosed with acute ischemic stroke and hospitalized for treatment.
å…¥é€‰æ ‡å‡†åŒ…æ‹¬ï¼šï¼ˆ1ï¼‰æ‚£è€…å…¥é™¢æ—¶å¹´é¾„18-90å²;ï¼ˆ2ï¼‰è¯Šæ–­ä¸ºæ€¥æ€§ç¼ºè¡€æ€§å’ä¸­å¹¶ä½é™¢æ²»ç–—ã€‚

Exclusion criteria were: (1) History of stroke or transient ischemic attack (TIA); (2) History of conditions such as traumatic brain injury, intracranial tumors, or cerebral vascular malformations that may cause epilepsy; (3) History of epilepsy or prior antiseizure medication use for seizure prevention or for other diseases (e.g. migraine or psychiatric disorders); (4) Death within 72 hr after stroke onset.
æ’é™¤æ ‡å‡†ä¸ºï¼šï¼ˆ1ï¼‰å’ä¸­æˆ–çŸ­æš‚æ€§è„‘ç¼ºè¡€å‘ä½œï¼ˆTIAï¼‰å²;ï¼ˆ2ï¼‰å¯èƒ½å¯¼è‡´ç™«ç—«çš„åˆ›ä¼¤æ€§è„‘æŸä¼¤ã€é¢…å†…è‚¿ç˜¤æˆ–è„‘è¡€ç®¡ç•¸å½¢ç­‰ç–¾ç—…å²;ï¼ˆ3ï¼‰ç™«ç—«å²æˆ–æ—¢å¾€ä½¿ç”¨æŠ—ç™«ç—«è¯ç‰©é¢„é˜²ç™«ç—«å‘ä½œæˆ–æ²»ç–—å…¶ä»–ç–¾ç—…ï¼ˆå¦‚åå¤´ç—›æˆ–ç²¾ç¥ç–¾ç—…ï¼‰;ï¼ˆ4ï¼‰å’ä¸­å‘ä½œå 72 å°æ—¶å†…æ­»äº¡ã€‚

De-identified data from relevant patients were collected to build a multi-modal stroke patient database. The study protocol was approved by the Ethics Committees of Chongqing University Center Hospital, Chongqing University Qianjiang Central Hospital, Bishan District Peopleâ€™s Hospital, and Yubei District Traditional Chinese Medicine Hospital.
æ”¶é›†ç›¸å…³æ‚£è€…çš„å»è¯†åˆ«æ•°æ®ï¼Œä»¥å»ºç«‹å¤šæ¨¡å¼å’ä¸­æ‚£è€…æ•°æ®åº“ã€‚æœ¬ç ”ç©¶æ–¹æ¡ˆè·å¾—äº†é‡åº†å¤§å­¦ä¸­å¿ƒåŒ»é™¢ã€é‡åº†å¤§å­¦é»”æ±Ÿä¸­å¿ƒåŒ»é™¢ã€ç’§å±±åŒºäººæ°‘åŒ»é™¢ã€æ¸åŒ—åŒºä¸­åŒ»é™¢ä¼¦ç†å§”å‘˜ä¼šçš„æ‰¹å‡†ã€‚

The selection process is outlined in Figure 4. A total of 42,079 records were retrieved from the stroke database, and 24,733 patients were diagnosed with new-onset ischemic or lacunar stroke. Patients with hemorrhagic strokes (4565), a history of stroke (2154), TIA (3570), unclear-cause strokes (561), and those with missing essential data (6496) were excluded. Additionally, patients whose seizures may have been caused by other factors (such as brain tumors, intracranial vascular malformations, or traumatic brain injury) (865), those with a history of seizures (152), and those who died in the hospital (1444) were excluded. Patients lost to follow-up (those without outpatient records or unreachable by phone) or who died within three months of the stroke incident (813) were also excluded. In total, 21,459 cases were included in the study.
é€‰æ‹©è¿‡ç¨‹åœ¨ Figure 4 ä¸­æ¦‚è¿°ã€‚ä»å’ä¸­æ•°æ®åº“ä¸­å…±æ£€ç´¢åˆ° 42ï¼Œ079 æ¡è®°å½•ï¼Œ24ï¼Œ733 ä¾‹æ‚£è€…è¢«è¯Šæ–­ä¸ºæ–°å‘ç¼ºè¡€æ€§æˆ–è…”éš™æ€§å’ä¸­ã€‚æ’é™¤äº†å‡ºè¡€æ€§å’ä¸­ï¼ˆ4565 ä¾‹ï¼‰ã€å’ä¸­å²ï¼ˆ2154 ä¾‹ï¼‰ã€TIAï¼ˆ3570 ä¾‹ï¼‰ã€åŸå› ä¸æ˜å’ä¸­ï¼ˆ561 ä¾‹ï¼‰å’ŒåŸºæœ¬æ•°æ®ç¼ºå¤±ï¼ˆ6496 ä¾‹ï¼‰çš„æ‚£è€…ã€‚æ­¤å¤–ï¼Œæ’é™¤äº†ç™«ç—«å‘ä½œå¯èƒ½ç”±å…¶ä»–å› ç´ ï¼ˆå¦‚è„‘è‚¿ç˜¤ã€é¢…å†…è¡€ç®¡ç•¸å½¢æˆ–åˆ›ä¼¤æ€§è„‘æŸä¼¤ï¼‰å¼•èµ·çš„æ‚£è€…ï¼ˆ865ï¼‰ã€æœ‰ç™«ç—«å‘ä½œå²çš„æ‚£è€…ï¼ˆ152ï¼‰å’Œåœ¨åŒ»é™¢æ­»äº¡çš„æ‚£è€…ï¼ˆ1444ï¼‰ã€‚å¤±è®¿æ‚£è€…ï¼ˆæ²¡æœ‰é—¨è¯Šè®°å½•æˆ–æ— æ³•é€šè¿‡ç”µè¯è”ç³»çš„æ‚£è€…ï¼‰æˆ–åœ¨å’ä¸­äº‹ä»¶å‘ç”Ÿå 3 ä¸ªæœˆå†…æ­»äº¡çš„æ‚£è€…ï¼ˆ813ï¼‰ä¹Ÿè¢«æ’é™¤åœ¨å¤–ã€‚å…±æœ‰ 21ï¼Œ459 ä¾‹ç—…ä¾‹çº³å…¥ç ”ç©¶ã€‚















### Data collection  æ•°æ®æ”¶é›†
Relevant records and data were extracted from hospital databases. PostgreSQL was used to manage the data, with Structured Query Language (SQL) queries organized as follows:
ä»åŒ»é™¢æ•°æ®åº“ä¸­æå–ç›¸å…³è®°å½•å’Œæ•°æ®ã€‚PostgreSQL ç”¨äºç®¡ç†æ•°æ®ï¼Œç»“æ„åŒ–æŸ¥è¯¢è¯­è¨€ï¼ˆSQLï¼‰æŸ¥è¯¢ç»„ç»‡å¦‚ä¸‹ï¼š

General Information: This included gender, age, and NIH Stroke Scale (NIHSS) score at admission.
ä¸€èˆ¬ä¿¡æ¯ï¼šåŒ…æ‹¬æ€§åˆ«ã€å¹´é¾„å’Œå…¥é™¢æ—¶çš„ NIH å’ä¸­é‡è¡¨ï¼ˆNIHSSï¼‰è¯„åˆ†ã€‚

Comorbidities and Complications: Conditions such as uremia, deep vein thrombosis (DVT), diabetes mellitus, hypertension, coronary atherosclerosis, atrial fibrillation, cerebral hernia, hydrocephalus, hypoproteinemia, hyperuricemia, hyperlipidemia, internal carotid stenosis, and common carotid stenosis were recorded.
åˆå¹¶ç—‡å’Œå¹¶å‘ç—‡ï¼šè®°å½•å°¿æ¯’ç—‡ã€æ·±é™è„‰è¡€æ “å½¢æˆï¼ˆDVTï¼‰ã€ç³–å°¿ç—…ã€é«˜è¡€å‹ã€å† çŠ¶åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–ã€æˆ¿é¢¤ã€è„‘ç–ã€è„‘ç§¯æ°´ã€ä½è›‹ç™½è¡€ç—‡ã€é«˜å°¿é…¸è¡€ç—‡ã€é«˜è„‚è¡€ç—‡ã€é¢ˆå†…åŠ¨è„‰ç‹­çª„å’Œé¢ˆæ€»åŠ¨è„‰ç‹­çª„ç­‰ç–¾ç—…ã€‚

Brain Involvement (CT or MRI records): Involvement of cortical lobes (frontal, parietal, temporal, occipital, and insular) and subcortical areas (basal ganglia, internal capsule, brain stem, cerebellum, periventricular area, centrum semiovale, and thalamus) was noted. Cortical involvement was scored with each lobe contributing 1 point, and subcortical involvement was scored similarly, with each area contributing 1 point.
è„‘éƒ¨å—ç´¯ï¼ˆCT æˆ– MRI è®°å½•ï¼‰ï¼šæ³¨æ„åˆ°çš®è´¨å¶ï¼ˆé¢å¶ã€é¡¶å¶ã€é¢å¶ã€æ•å¶å’Œå²›å¶ï¼‰å’Œçš®è´¨ä¸‹åŒºåŸŸï¼ˆåŸºåº•èŠ‚ã€å†…å›Šã€è„‘å¹²ã€å°è„‘ã€å®¤å‘¨åŒºã€åŠåµåœ†ä¸­å¿ƒå’Œä¸˜è„‘ï¼‰å—ç´¯ã€‚çš®è´¨å—ç´¯è¯„åˆ†ï¼Œæ¯ä¸ªå¶è´¡çŒ® 1 åˆ†ï¼Œçš®è´¨ä¸‹å—ç´¯è¯„åˆ†ç›¸ä¼¼ï¼Œæ¯ä¸ªåŒºåŸŸè´¡çŒ® 1 åˆ†ã€‚

Vascular Involvement (CTA, MRA, or DSA records): The presence of vascular stenosis or occlusion in the anterior cerebral artery (ACA), middle cerebral artery (MCA), posterior cerebral artery (PCA), vertebral artery (VA), and basilar artery (BA) was documented.
è¡€ç®¡å—ç´¯ï¼ˆCTAã€MRA æˆ– DSA è®°å½•ï¼‰ï¼šè®°å½•å¤§è„‘å‰åŠ¨è„‰ï¼ˆACAï¼‰ã€å¤§è„‘ä¸­åŠ¨è„‰ï¼ˆMCAï¼‰ã€å¤§è„‘ååŠ¨è„‰ï¼ˆPCAï¼‰ã€æ¤åŠ¨è„‰ï¼ˆVAï¼‰å’ŒåŸºåº•åŠ¨è„‰ï¼ˆBAï¼‰ä¸­å­˜åœ¨è¡€ç®¡ç‹­çª„æˆ–é—­å¡ã€‚

Key Laboratory Indicators: These included blood lipid levels such as triglycerides, high-density lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL); liver function markers such as alanine transaminase (ALT), aspartate aminotransferase (AST), bilirubin, and albumin; renal function markers such as urea, blood uric acid (BUA), and creatinine; blood gas parameters such as lactate, anion gap, and total carbon dioxide (TCO2); coagulation markers such as international normalized ratio (INR), prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), D-dimer, and fibrinogen; and myocardial enzymes such as creatine kinase (CK), creatine kinase isoenzyme (CK-MB), lactate dehydrogenase (LDH), ischemic modified albumin (IMA), and Î±-hydroxybutyrate dehydrogenase (HBDH).
å…³é”®å®éªŒå®¤æŒ‡æ ‡ï¼šè¿™äº›æŒ‡æ ‡åŒ…æ‹¬è¡€è„‚æ°´å¹³ï¼Œå¦‚ç”˜æ²¹ä¸‰é…¯ã€é«˜å¯†åº¦è„‚è›‹ç™½èƒ†å›ºé†‡ï¼ˆHDLï¼‰å’Œä½å¯†åº¦è„‚è›‹ç™½èƒ†å›ºé†‡ï¼ˆLDLï¼‰;è‚åŠŸèƒ½æŒ‡æ ‡ï¼Œå¦‚ä¸™æ°¨é…¸è½¬æ°¨é…¶ï¼ˆALTï¼‰ã€å¤©å†¬æ°¨é…¸è½¬æ°¨é…¶ï¼ˆASTï¼‰ã€èƒ†çº¢ç´ å’Œç™½è›‹ç™½;è‚¾åŠŸèƒ½æŒ‡æ ‡ï¼Œå¦‚å°¿ç´ ã€è¡€å°¿é…¸ï¼ˆBUAï¼‰å’Œè‚Œé…;è¡€æ°”å‚æ•°ï¼Œå¦‚ä¹³é…¸ã€é˜´ç¦»å­é—´éš™å’Œæ€»äºŒæ°§åŒ–ç¢³ï¼ˆTCO 2ï¼‰;å‡è¡€æ ‡å¿—ç‰©å¦‚å›½é™…æ ‡å‡†åŒ–æ¯”ç‡ï¼ˆINRï¼‰ã€å‡è¡€é…¶åŸæ—¶é—´ï¼ˆPTï¼‰ã€æ´»åŒ–éƒ¨åˆ†å‡è¡€æ´»é…¶æ—¶é—´ï¼ˆAPTTï¼‰ã€å‡è¡€é…¶æ—¶é—´ï¼ˆTTï¼‰ã€D-äºŒèšä½“å’Œçº¤ç»´è›‹ç™½åŸ;å’Œå¿ƒè‚Œé…¶å¦‚è‚Œé…¸æ¿€é…¶ï¼ˆCKï¼‰ã€è‚Œé…¸æ¿€é…¶åŒå·¥é…¶ï¼ˆCK-MBï¼‰ã€ä¹³é…¸è„±æ°¢é…¶ï¼ˆLDHï¼‰ã€ç¼ºè¡€ä¿®é¥°ç™½è›‹ç™½ï¼ˆIMAï¼‰å’ŒÎ±-ç¾ŸåŸºä¸é…¸è„±æ°¢é…¶ï¼ˆHBDHï¼‰ã€‚





### Data processing and model building    æ•°æ®å¤„ç†å’Œæ¨¡å‹å»ºç«‹
Processing of Missing Data: Laboratory indicators were recorded from the first set of tests after stroke admission. Indicators with more than 10% missing data were excluded. Remaining indicators with missing values were imputed using the random forest algorithm with default parameters. Features were processed in order of increasing missing data to minimize imputation complexity. During imputation, missing values in other features were temporarily replaced with 0, and predicted values were inserted into the original feature matrix before moving to the next feature. This process continued until all features were complete.
ç¼ºå¤±æ•°æ®çš„å¤„ç†ï¼šè®°å½•ä¸­é£å…¥é™¢åç¬¬ä¸€ç»„æ£€æŸ¥çš„å®éªŒå®¤æŒ‡æ ‡ã€‚ç¼ºå¤±æ•°æ®è¶…è¿‡10%çš„æŒ‡æ ‡è¢«æ’é™¤åœ¨å¤–ã€‚å…¶ä½™ç¼ºå¤±å€¼çš„æŒ‡æ ‡é‡‡ç”¨éšæœºæ£®æ—ç®—æ³•å’Œé»˜è®¤å‚æ•°è¿›è¡Œä¼°ç®—ã€‚æŒ‰ç…§å¢åŠ ç¼ºå¤±æ•°æ®çš„é¡ºåºå¤„ç†ç‰¹å¾ï¼Œä»¥æœ€å¤§é™åº¦åœ°å‡å°‘æ’è¡¥å¤æ‚æ€§ã€‚åœ¨æ’è¡¥è¿‡ç¨‹ä¸­ï¼Œå…¶ä»–ç‰¹å¾ä¸­çš„ç¼ºå¤±å€¼æš‚æ—¶ç”¨0æ›¿æ¢ï¼Œé¢„æµ‹å€¼åœ¨ç§»åŠ¨åˆ°ä¸‹ä¸€ä¸ªç‰¹å¾ä¹‹å‰æ’å…¥åˆ°åŸå§‹ç‰¹å¾çŸ©é˜µä¸­ã€‚è¿™ä¸ªè¿‡ç¨‹ä¸€ç›´æŒç»­åˆ°æ‰€æœ‰åŠŸèƒ½å®Œæˆã€‚

Distribution of Characteristics: Univariate analysis was performed to compare the distribution of characteristics between PSE-negative and PSE-positive groups. The dataset was then divided into a training set and a test set in a 7:3 ratio.
ç‰¹å¾åˆ†å¸ƒï¼šè¿›è¡Œå•å› ç´ åˆ†æï¼Œæ¯”è¾ƒ PSE é˜´æ€§å’Œ PSE é˜³æ€§ç»„ä¹‹é—´çš„ç‰¹å¾åˆ†å¸ƒã€‚ç„¶åå°†æ•°æ®é›†ä»¥ 7ï¼š3 çš„æ¯”ä¾‹åˆ†ä¸ºè®­ç»ƒé›†å’Œæµ‹è¯•é›†ã€‚

Handling Imbalanced Data: Due to the low incidence of PSE and the small proportion of positive cases, positive data in the training set were augmented using the Synthetic Minority Over-sampling Technique combined with Edited Nearest Neighbors (SMOTEENN). The SMOTEENN method from the imblearn Python package was applied with default parameters, and a random seed of 42 was set for reproducibility.
å¤„ç†ä¸å¹³è¡¡æ•°æ®ï¼šç”±äº PSE çš„å‘ç—…ç‡ä½ï¼Œé˜³æ€§ç—…ä¾‹çš„æ¯”ä¾‹å°ï¼Œè®­ç»ƒé›†ä¸­çš„é˜³æ€§æ•°æ®ä½¿ç”¨åˆæˆå°‘æ•°è¿‡é‡‡æ ·æŠ€æœ¯ç»“åˆç¼–è¾‘æœ€è¿‘é‚»ï¼ˆSMOTEENNï¼‰è¿›è¡Œäº†æ‰©å¢ã€‚ä½¿ç”¨é»˜è®¤å‚æ•°åº”ç”¨ imblearn Python åŒ…ä¸­çš„ SMOTEENN æ–¹æ³•ï¼Œå¹¶å°†éšæœºç§å­è®¾ç½®ä¸º 42 ä»¥ç¡®ä¿é‡ç°æ€§ã€‚

Processing of Categorical Data: Categorical variables were transformed using one-hot encoding. The LASSO method was then applied to the training set to identify the most important features.
åˆ†ç±»æ•°æ®çš„å¤„ç†ï¼šä½¿ç”¨ç‹¬çƒ­ç¼–ç è½¬æ¢åˆ†ç±»å˜é‡ã€‚ç„¶åå°† LASSO æ–¹æ³•åº”ç”¨äºè®­ç»ƒé›†ä»¥è¯†åˆ«æœ€é‡è¦çš„ç‰¹å¾ã€‚

Model Building: LASSO regression was used to select the 20 most important features. Nine widely used machine learning methods were employed, including Naive Bayes, Logistic Regression, Decision Tree, Random Forest, Gradient Boosting, Multi-Layer Perceptron, XGBoost, LightGBM, and K-Nearest Neighbors. Hyperparameters were optimized through grid search to enhance model performance. Evaluation metrics included accuracy, sensitivity, specificity, F1-score, positive predictive value, and negative predictive value. Additionally, ROC curves, calibration curves, and decision curves were generated to assess model performance. An independent external validation dataset was used to evaluate the modelâ€™s generalizability. The SHAP algorithm was then applied to the best-performing model to interpret feature contributions and their clinical relevance. This approach enabled the development of a robust machine learning model with strong predictive performance and interpretability, providing valuable support for clinical decision-making.
æ¨¡å‹æ„å»ºï¼šä½¿ç”¨ LASSO å›å½’æ¥é€‰æ‹© 20 ä¸ªæœ€é‡è¦çš„ç‰¹å¾ã€‚ä½¿ç”¨äº†ä¹ç§å¹¿æ³›ä½¿ç”¨çš„æœºå™¨å­¦ä¹ æ–¹æ³•ï¼ŒåŒ…æ‹¬æœ´ç´ è´å¶æ–¯ï¼Œé€»è¾‘å›å½’ï¼Œå†³ç­–æ ‘ï¼Œéšæœºæ£®æ—ï¼Œæ¢¯åº¦æå‡ï¼Œå¤šå±‚æ„ŸçŸ¥å™¨ï¼ŒXGBoostï¼ŒLightGBM å’Œ K æœ€è¿‘é‚»ã€‚é€šè¿‡ç½‘æ ¼æœç´¢ä¼˜åŒ–è¶…å‚æ•°ï¼Œä»¥æé«˜æ¨¡å‹æ€§èƒ½ã€‚è¯„ä»·æŒ‡æ ‡åŒ…æ‹¬å‡†ç¡®æ€§ã€çµæ•åº¦ã€ç‰¹å¼‚æ€§ã€F1 è¯„åˆ†ã€é˜³æ€§é¢„æµ‹å€¼å’Œé˜´æ€§é¢„æµ‹å€¼ã€‚æ­¤å¤–ï¼Œç”Ÿæˆ ROC æ›²çº¿ã€æ ¡å‡†æ›²çº¿å’Œå†³ç­–æ›²çº¿ä»¥è¯„ä¼°æ¨¡å‹æ€§èƒ½ã€‚ä¸€ä¸ªç‹¬ç«‹çš„å¤–éƒ¨éªŒè¯æ•°æ®é›†è¢«ç”¨æ¥è¯„ä¼°æ¨¡å‹çš„æ³›åŒ–èƒ½åŠ›ã€‚ç„¶åå°† SHAP ç®—æ³•åº”ç”¨äºæ€§èƒ½æœ€ä½³çš„æ¨¡å‹ï¼Œä»¥è§£é‡Šç‰¹å¾è´¡çŒ®åŠå…¶ä¸´åºŠç›¸å…³æ€§ã€‚ è¿™ç§æ–¹æ³•èƒ½å¤Ÿå¼€å‘å‡ºå…·æœ‰å¼ºå¤§é¢„æµ‹æ€§èƒ½å’Œå¯è§£é‡Šæ€§çš„å¼ºå¤§æœºå™¨å­¦ä¹ æ¨¡å‹ï¼Œä¸ºä¸´åºŠå†³ç­–æä¾›æœ‰ä»·å€¼çš„æ”¯æŒã€‚






### Statistical approach  ç»Ÿè®¡æ–¹æ³•
PostgreSQL v15 (http://www.postgresql.org/) was used to search and extract data from the local database. Statistical analysis was performed using the open-source Scipy.stats package in Python. The details of the univariate significance analysis were as follows:
ä½¿ç”¨ PostgreSQL v15ï¼ˆ http://www.postgresql.org/ ï¼‰ä»æœ¬åœ°æ•°æ®åº“ä¸­æœç´¢å’Œæå–æ•°æ®ã€‚ä½¿ç”¨ Python ä¸­çš„å¼€æº Scipy.stats åŒ…è¿›è¡Œç»Ÿè®¡åˆ†æã€‚å•å˜é‡æ˜¾è‘—æ€§åˆ†æçš„è¯¦æƒ…å¦‚ä¸‹ï¼š

The Shapiro-Wilk test was used to assess the normality of each featureâ€™s distribution. For features not following a normal distribution, the Mann-Whitney U test was used to evaluate their significance in relation to the target variable. For features with a normal distribution, the Levene test was performed to evaluate the homogeneity of variances. Features with homogeneous variances were analyzed using the Studentâ€™s t-test, while those with heterogeneous variances were analyzed using Welchâ€™s t-test.
Shapiro-Wilk æ£€éªŒç”¨äºè¯„ä¼°æ¯ä¸ªç‰¹å¾åˆ†å¸ƒçš„æ­£æ€æ€§ã€‚å¯¹äºä¸éµå¾ªæ­£æ€åˆ†å¸ƒçš„ç‰¹å¾ï¼Œä½¿ç”¨ Mann-Whitney U æ£€éªŒè¯„ä»·å…¶ç›¸å¯¹äºç›®æ ‡å˜é‡çš„æ˜¾è‘—æ€§ã€‚å¯¹äºå…·æœ‰æ­£æ€åˆ†å¸ƒçš„ç‰¹å¾ï¼Œè¿›è¡Œ Levene æ£€éªŒä»¥è¯„ä»·æ–¹å·®é½æ€§ã€‚ä½¿ç”¨ Student t æ£€éªŒåˆ†æå…·æœ‰é½æ€§æ–¹å·®çš„ç‰¹å¾ï¼Œè€Œä½¿ç”¨ Welch t æ£€éªŒåˆ†æå…·æœ‰å¼‚æ€§æ–¹å·®çš„ç‰¹å¾ã€‚

Confidence intervals for AUC values and Brier scores were calculated using 1000 bootstrap resampling iterations. Binary classification thresholds for predicted probabilities were set using the maximum Youden index derived from the training cohort. A two-tailed p-value of less than 0.05 was considered statistically significant throughout the study.
AUC å€¼å’Œ Brier è¯„åˆ†çš„ç½®ä¿¡åŒºé—´ä½¿ç”¨ 1000 æ¬¡ bootstrap é‡æ–°éªŒè¯è¿­ä»£è®¡ç®—ã€‚é¢„æµ‹æ¦‚ç‡çš„äºŒå…ƒåˆ†ç±»é˜ˆå€¼ä½¿ç”¨ä»è®­ç»ƒç¾¤ç»„å¯¼å‡ºçš„æœ€å¤§ Youden æŒ‡æ•°æ¥è®¾å®šã€‚åœ¨æ•´ä¸ªç ”ç©¶æœŸé—´ï¼Œè®¤ä¸ºåŒå°¾ p å€¼å°äº 0.05 å…·æœ‰ç»Ÿè®¡å­¦æ˜¾è‘—æ€§ã€‚

All code used in this study is available at https://github.com/conanan/lasso-ml (copy archived at conanan, 2024).
æœ¬ç ”ç©¶ä¸­ä½¿ç”¨çš„æ‰€æœ‰ä»£ç å¯åœ¨ https://github.com/conanan/lasso-ml ä¸­è·å¾—ï¼ˆå‰¯æœ¬å­˜æ¡£äº conanan, 2024 ï¼‰ã€‚


## Conclusion  ç»“è®º
An interpretable machine learning model was developed to predict the risk of PSE in hospitalized patients with ischemic stroke. Using a large dataset of medical records, the model demonstrated strong predictive performance for PSE. Key predictors identified by the model include NIHSS, D-dimer, lactate, and WBC, along with liver function and cardiac enzyme profile indicators. The modelâ€™s transparency and interpretability can build trust among clinicians and support decision-making. While the results are promising, further prospective studies are necessary to validate the clinical utility of this tool before it can be applied in real-world settings.
å¼€å‘äº†ä¸€ç§å¯è§£é‡Šçš„æœºå™¨å­¦ä¹ æ¨¡å‹æ¥é¢„æµ‹ç¼ºè¡€æ€§å’ä¸­ä½é™¢æ‚£è€…çš„ PSE é£é™©ã€‚ä½¿ç”¨å¤§å‹åŒ»ç–—è®°å½•æ•°æ®é›†ï¼Œè¯¥æ¨¡å‹å¯¹ PSE è¡¨ç°å‡ºå¼ºå¤§çš„é¢„æµ‹æ€§èƒ½ã€‚è¯¥æ¨¡å‹ç¡®å®šçš„å…³é”®é¢„æµ‹å› å­åŒ…æ‹¬ NIHSSã€D-äºŒèšä½“ã€ä¹³é…¸å’Œ WBCï¼Œæ²¿ç€è‚åŠŸèƒ½å’Œå¿ƒè‚Œé…¶è°±æŒ‡æ ‡ã€‚è¯¥æ¨¡å‹çš„é€æ˜åº¦å’Œå¯è§£é‡Šæ€§å¯ä»¥åœ¨ä¸´åºŠåŒ»ç”Ÿä¹‹é—´å»ºç«‹ä¿¡ä»»å¹¶æ”¯æŒå†³ç­–ã€‚è™½ç„¶ç»“æœæ˜¯æœ‰å¸Œæœ›çš„ï¼Œä½†åœ¨å°†å…¶åº”ç”¨äºç°å®ä¸–ç•Œä¹‹å‰ï¼Œè¿˜éœ€è¦è¿›ä¸€æ­¥çš„å‰ç»æ€§ç ”ç©¶æ¥éªŒè¯è¯¥å·¥å…·çš„ä¸´åºŠå®ç”¨æ€§ã€‚


## Acknowledgements  ç¡®è®¤
The authors would like to thank their colleagues in the information and imaging departments for their hard work contributing to the final research results.
ä½œè€…è¦æ„Ÿè°¢ä»–ä»¬åœ¨ä¿¡æ¯å’Œæˆåƒéƒ¨é—¨çš„åŒäº‹ï¼Œæ„Ÿè°¢ä»–ä»¬ä¸ºæœ€ç»ˆç ”ç©¶ç»“æœæ‰€åšçš„è¾›å‹¤å·¥ä½œã€‚

## Funding Statement  èµ„é‡‘æŠ¥è¡¨
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
èµ„åŠ©è€…ä¸å‚ä¸ç ”ç©¶è®¾è®¡ã€æ•°æ®æ”¶é›†å’Œè§£é‡Šï¼Œä¹Ÿä¸å‚ä¸å†³å®šæ˜¯å¦å°†ç ”ç©¶æˆæœæäº¤å‡ºç‰ˆã€‚


## Contributor Information  è´¡çŒ®è€…ä¿¡æ¯
Shanshan Tian, Email: 710836163@qq.com.
ç”°çŠçŠï¼Œé‚®ç®±ï¼š710836163@qq.comã€‚

Yongbing Deng, Email: dyb0913@cqu.edu.cn.
é‚“æ°¸å…µï¼Œç”µå­é‚®ç®±ï¼šdyb0913@cqu.edu.cnã€‚

Alan Talevi, National University of La Plata, Argentina.
é˜¿å…°Â·å¡”è±ç»´ï¼Œé˜¿æ ¹å»·æ‹‰æ™®æ‹‰å¡”å›½ç«‹å¤§å­¦ã€‚

Eduardo L Franco, McGill University, Canada.
Eduardo L Francoï¼ŒåŠ æ‹¿å¤§éº¦å‰å°”å¤§å­¦ã€‚


## Funding Information  èµ„åŠ©ä¿¡æ¯
This paper was supported by the following grants:
æœ¬è®ºæ–‡å¾—åˆ°äº†ä»¥ä¸‹èµ æ¬¾ï¼š

Central University Basic Research Fund of China 2023CDJYGRH-ZD06 to Yongbing Deng.
ä¸­å¤®å¤§å­¦åŸºç¡€ç ”ç©¶åŸºé‡‘ 2023 CDJYGRH-ZD 06 ç»™é‚“æ°¸å…µã€‚

Emergency Medicine chongqing Key Laboratory Talent Innovation and development joint fund project 2024RCCX10 to Yongbing Deng.
æ€¥è¯ŠåŒ»å­¦é‡åº†å¸‚é‡ç‚¹å®éªŒå®¤äººæ‰åˆ›æ–°å‘å±•è”åˆåŸºé‡‘é¡¹ç›® 2024RCCX10 ç»™é‚“æ°¸å…µã€‚











